key: cord-0059763-fzdqlagn
authors: Sergi, Consolato M.
title: Lower Respiratory Tract
date: 2020-10-29
journal: Pathology of Childhood and Adolescence
DOI: 10.1007/978-3-662-59169-7_2
sha: 0d7ac0118cc86bc929adf3912e2ee5454aa7995e
doc_id: 59763
cord_uid: fzdqlagn

The respiratory system is crucial in the life of some overlapping specialties in medicine. In utero, the lung faces a change of the structure which is rarely seen in any other systems. The very myxoid tissue- and glycogen-rich pseudoglandular phase does not become mature that only in the late infancy and early childhood. Respiratory disease in the newborn is a well-known complication of prematurity, but in the last decade, a large number of entities have been added to the chILD or Children’s Interstitial Lung Disease adding complexity to the adult interstitial lung disease. In fact, youth may develop both pediatric and adult interstitial lung diseases, and pediatricians and pathologists should be aware of the pitfalls in not addressing an adult interstitial lung disease correctly in an adolescent. Some congenital anomalies of the abnormal driven foregut budding of the lung development may also be considered as an essential topic in studying pediatrics and adolescence. This chapter is completed with more than 400 photographs illustrating several lines of abnormal processes that may be present in a developing lung. Similar to non-neoplastic disease, both adult and specific pediatric neoplastic lung diseases need to get attention to avoid the possibility of pitfalls. In the last decade, some case reports of pulmonary carcinoma and malignant mesothelioma of the pleura have been reported in children adding complexity in carcinogenesis of this very complex organ. The molecular genetics has helped to clarify several carcinogenetic pathways not anymore limited to DICER1 gene mutations identified in pleuropulmonary blastoma.

Lung development as endodermal derivate is central in the pathology of children and youth because the lung maturation is completed only after birth and precisely runs all through infancy until the age of 8 years. The acinus is the terminal respiratory unit. Parameters of lung maturity are the Wigglesworth coefficient and the radial alveolar count (Box 2.1). To study the lung maturity in open lung biopsies or babies who died during the pregnancy may be challenging. The collapsed lung specimen may jeopardize the proper evaluation. Moreover, many parameters may not be in line with the somatic growth. Effective and efficient criteria for the diagnosis of hypoplastic lungs have been searched for a long time. Wigglesworth proposed a coefficient considering his tremendous previous work in perinatal pathology. Wigglesworth focused on the ratio of lung weight to body weight and stated that this procedure is the most practical means of overcoming the intrauterine challenges. An LW/BW ratio ("lung weight/body weight") ratio of ≤0.012 is generally associated with a reduction in alveolar number as indicated by the radial alveolar count (RAC) (vide infra). Wigglesworth and Desai considered appropriate to define lung hypoplasia in infants or fetuses with a gestational age <28 weeks as half the mean LW/BW ratio of the 20-27-week group (i.e., <0.015) rather than taking the value of 0.012 used for infants with gestational age ≥ 28 weeks. These authors found that babies with renal agenesis, severe renal cystic dysplasia, or total urinary outflow obstruction had a lung DNA content at 34-40 weeks' gestation equivalent to that found in the normal fetal lung at 20-22 weeks' gestational age. In normal fetuses, i.e., fetuses with normal karyotype and without external or internal congenital anomalies, the graph of total lung DNA increase shows that the lung cell population doubles between 17 and 20 weeks' gestation. The RAC is calculated according to Emery and Mithal's method. RAC <2.0 is usually found in the lungs of fetuses aged less than 18 weeks. A considerable interindividual variation is present between 18 and 25 weeks. In fetuses with a gestational age between 25 and 30 weeks, an increase in RAC occurs. RAC >6 occurs only in fetuses at near full-term birth.

Since the estimation of RAC overcomes the effects of varying degrees of alveolar collapse, RAC is useful also for the determination of the fetal age in cases of advanced putrefaction (Figs. 2.1 and 2.2). Some procedures should be in line to ensure reproducibility in the RAC calculation. The chILD Pathology Co-operative Group proposed some extremely useful guidelines (Langston et al. 2006 ) (here slightly modified), which include the proper handling of a sterile lung specimen received unfixed from the pediatric surgeon or nurse directly from the pediatric operating room. We advise to sample tissue for microbiology directly in the operating room avoiding the potential contamination of transportation and pathology laboratory. Specifically, 10% of tissue is destined to the microbiology laboratory for microbiology cultures to identify potential viral, H&E) showing a prominent interstitium rich in interstitial fluid; (b) high magnification at 14th weeks' gestation with cylindrical appearance of the future alveoli, which at this stage are labeled pseudoglands (H&E staining, 400×); (c) EvG stain highlights the addensation of elastic fibers around the pseudoglands (EvG, 100×); (d) the Periodic Acid Schiff staining, which is specific for glycogen, highlights the glycogen-rich content of the lung from a 14th weeks' gestation old fetus (PAS, 400×) ; (e) saccular stage of the lung showing less edema-rich interstitium and abnormal ovoidal shape ("sacculi") of the lung architecture. The epithelium is still cylindrical but at places may become cuboidal; (f), (g), and (h) come from a mature newborn with alveolar stage of development but suffering from birth asphyxia with presence of squamous lamellae in some of the alveolar structure. The blood vessels have a physiologic hypertrophy of the media at this age. No hyaline membranes can be recognized (H&E staining, 200× (H&E staining, 40× and 200×) ; (c) lung development disorder in 1-year-old infant with alveolar enlargement and simplification, lobular remodeling with increased interstitial smooth muscle and mild fibrosis, interstitial inflammation, patchy, mild, peribronchiolar metaplasia and mucus stasis, pulmonary arteriopathy with mild to moderate muscularization, and myointimal proliferation (H&E staining, 50×); (d) Chest X-ray of an immature baby showing a granular-looking lung pattern with non-areated areas ("salt" granules) and aerated areas ("pepper" granules). (e) 30 weeks' gestation premature baby with GBS-Sepsis, SPH and normal heart; (f) 30 weeks' gestation premature baby with hyline membrane disease (H&E staining, 50×); (g) PAS-positive hyaline membranes in a premature baby (PAS staining, 50×); (h) obliteration of the alveolar structures by epithelial squames and neutrophils in a newborn with meconium aspiration syndrome (H&E staining, 50×) bacterial, and fungal microorganisms, 10% of tissue is snap frozen (-70°C) for molecular biology studies (e.g., surfactant genes mutations), 10% of tissue is snap frozen (-70°C) in cryomatrix embedding resin for immunofluoresence, laser capture microdissection, or other studies requiring frozen tissue sections securing and supporting tissue with a firm bond with the specimen holder, <5% (usually three specimens of 1 mm 3 ) fixed in glutaraldehyde for transmission electron microscopy (multiple sites), 5% for flow cytometry for clonality and lymphocytic cell populations (e.g., post-transplant lymphoproliferative disorder) using Tissue Transport Medium or TTM (if TTM is not available, normal saline is the best choice), 0% touch preparations (imprints) for cytologic examination or rapid identification of organisms (two slides air dried and two alcohol fixed stained with Papanicolau staining and a Romanowskibased stain, e.g., Diff-Quik), 60% formalin inflation using a syringe and applying a gently infusion fixed for light microscopy. It is important to recall that the vials of glutaraldehyde 1%-2% solution are usually in the fridge (4 °C). On the other hand, glutaraldehyde seem to show no change in concentration after one year of storage at 25°C, but some glutaraldehyde products have shown a longer shelf life when they are placed in the 4 °C. TTM needs to be stored at 4°C for up to 1 month from the date of preparation. TTM vials should have an orange-pink appearance and a color change to bright pink indicates a pH change. At this point, TTM should be discarded. When the respiratory bronchiole is symmetrical, the geometric center of the lung specimen (histological slide) should be used as a starting point. In case the bronchiole is irregular, the starting point should be in the middle of the way between the most proximal part (i.e., the wall lined by conducting epithelium) and the first branch point. No count should be made if the respiratory bronchiole is nearer to the edge of the slide than to the most adjacent connective tissue septum. In fact, cutting issues may conceal an artifact. A closer septum might have been aloof in taking the paraffin block. Finally, all alveoli traversed by the perpendicular should be counted. In other terms, a perpendicular line is drawn from the midpoint of the most distal respiratory bronchiole (transition point from respiratory to alveolar epithelium) to the nearest connective tissue septum, and each saccule is counted along this line.

In Box 2.2, the RAC calculation is shown. Lobation: Right lung is trilobed, while the left lung is bilobed (the lingula of the left lung should be considered the equivalent of the right middle lobe). The lingula is often taken for sampling in case of suspicious interstitial lung disease. About the tracheal bifurcation, it occurs at the level of the 4th-5th ribs with the right main stem bronchus positioned more vertical than the left main stem bronchus. Lung aspiration is more frequent on the right side than on the left side. ciated with bilateral trilobed (right) lungs (~4/5 cases), asplenia, and an intact inferior vena cava (IVC), whereas left-sidedness is related to bilateral bilobed (left) lungs (~2/3 cases), polysplenia, and an interrupted IVC.

Moreover, some more words need to be spent on the trachea and bronchial system. The trachea and significant bronchi have C-shaped cartilage rings, which is of an obstacle to a full occlusion of the lumen by bronchoconstriction in comparison with the most distal airway structures that can be fully occluded. Bronchi have discontinuous plates of cartilage and are recognized explicitly by submucosal glands. The lungs have a dual arterial system: pulmonary and bronchial. Hemorrhagic infarction is possible if other than occlusion also stasis/left ventricular insufficiency is present. There is a single venous system: pulmonary. The pseudostratified ciliated columnar epithelium is from the larynx to bronchioles (except the vocal cords: squamous) with type I pneumocytes covering ~95% alveolar surface while type II pneumocytes covering the rest and contain lamellar bodies of surfactant.

Inhaled particles can reach the terminal stations of the acinus according to the size. If the particle size is >5 μm, it does usually impact high in airways and is cleared, and <1 μm typically remain suspended and are exhaled. Conversely, particles with a 1< Ø <5 μm reach the terminal airways and alveoli and deposit there eliciting no tissue reaction or a tissue reaction according to the chemical or physical composition of the particle. The pulmonary defense mechanisms are nasal riddance, a mucociliary clearance, and the alveolar macrophages (MΦ).

The anatomic and immunohistochemical characteristics of the pleura are summarized in Box 2.3.

Physiologically, the pleura play essential roles, including the crucial one that takes place when the individual breaths. The pleural cavity serves as optimal functioning of the lungs during breathing and contains pleural fluid, which acts as a "lubricant" allowing the pleurae to slide effortlessly against each other during respiratory movements. Pleural pathology is either autonomous in origin or secondary to some underlying pulmonary pathology (most of the cases), being co-involved due to the adhesion to the lung parenchyma.

The mnemonic word FACTS can be used to remember significant dysmorphology and perinatal airway diseases (Box 2.4). It includes Foregut cysts and bronchogenic cysts, Agenesis or hypoplasia (partial or total), CPAM (congenital pulmonary airway malformation) and Congenital emphysema (lobar overinflation), Tracheal and bronchial anomalies (atresia, stenosis, tracheoesophageal fistula), as well as Sequestrations and vascular abnormalities. It is important to remember that bronchogenic cysts and sequestrations have a systemic arterial supply and do not communicate with the tracheobronchial tree, while CPAMs have regular pulmonary arterial supply and do communicate with the tracheobronchial tree.

• Pleurae: 2, i.e., (1) visceral, coating the lung, and (2) parietal, adherent to the thoracic cage • Lining: Mesothelium constituted by mesothelial cells of mesodermal origin • Mesothelium distinctive features: tight apical junctions, desmosomes, long surface microvilli, and thick glycocalyx (pericellular matrix) • Non-neoplastic mesothelium reactivity: P53 (−) ≠ from mesothelioma (P53+) • Non-neoplastic mesothelium reactivity: EMA (dim) ≠ from mesothelioma (spikes) • Non-neoplastic mesothelium reactivity: DES (+) ≠ from mesothelioma (−) Notes: ≠ different; EMA, epithelial membrane antigen; DES, desmin

Foregut cysts may be of a bronchogenic, esophageal, or enteric type. The bronchogenic cyst is usually a mucinous cyst or an air containing extrapulmonary cavity, anywhere in the chest (adjacent to bronchi or bronchioles). It may be single, ranging from microscopic size to an effective Ø of ≥ 5 cm. Ciliated epithelium lines foregut cysts of bronchogenic type. The underlying connective tissue usually contains cartilage and submucous glands. Complications include mostly infections. If infection supervenes, progressive metaplasia of lining or total necrosis of the wall can ensue. Subsequently, this inflammatory process may lead to lung abscess (vide infra). Other complications may include rupture of the foregut cysts into either bronchi or pleural cavity ( Fig. 2.3 ). Cutaneous bronchogenic cysts may also occur and need to be differentiated by the branchial derivatives and thyroglossal duct cysts. The embryology and the lung development help in explaining the origin of broncho-genic cysts in the extrathoracic subcutaneous tissue. In the 5th week of gestation, the separation occurs of the primitive foregut. The laryngotracheal groove starts and determines the termination of the primitive foregut into two well specific but yet not well delineated structures, i.e., the dorsal and ventral structures. Two weeks later, at the 17th week of gestation, the laryngotracheal groove is complete determining two well-distinct embryonic structures, i.e., the ventral component forming the foregut and the dorsal element forming the lung buds. This period is crucial, and an abnormal process in the lung bud formation during this time implicates the origin of bronchogenic cysts. In the subcutaneous tissue of the chest (anterior side), bronchogenic cysts occur either by anterior migration of an intrathoracic bronchogenic cyst or by a sequester of the fusing sternal bars on the developing lung parenchyma. Conversely, extrathoracic cysts located in other sites (e.g., neck, shoulder, and chin) can be interpreted by the migration of these sequestered structures at their location in the developing embryo. They should not be construed as neoformations. A ciliated pseudostratified columnar epithelium covers the cutaneous bronchogenic cysts. This epithelium is commonly invariably interspersed with goblet cells, which may be recognized using special stains (alcian PAS or alcian pH 2.5). The cutaneous bronchogenic cysts also show other components, including cartilage, mucous glands, and smooth muscle fibers. The most common element is the smooth muscle layer. The differential diagnosis of a cutaneous bronchogenic cysts includes cutaneous ciliated cyst (lower extremities, female), thyroglossal duct cyst (midline, respiratory/squamous epithelium lining, TG (+), and TTF (+) thyroid follicles), epidermal inclusion cyst (stratified squamous epithelium), branchial cyst (stratified squamous epithelium and surrounding composed of lymphoid tissue), dermoid cyst (epidermis lining with several epidermal appendages), and trichilemmal cyst (squamous epithelium lining without an intervening granular cell layer). Although trichilemmal or pilar cysts arise mostly in body ares of high hair follicle concentrations (e.g., scalp), they can also be found everywhere. In one third of cases, trichilemmal cysts are solitary, but in two thirds they are multiple. The histology is paramount in giving the definitive diagnosis to the pediatric surgeon.

Agenesis of the lung is particularly rare and has been observed in very few cases from the literature. In lung agenesis, there is a total absence of any lung tissue. There is no foregut budding ab initio. In lung aplasia, there is an extreme imperfect development of the organ with some minimal primordial mass (the lung anlage is present). Lung aplasia is a rare congenital pathology in which there is the unilateral or bilateral absence of proper lung tissue. It is arguably distinguished from lung agenesis, the main difference being that there is a short blind-ending bronchus in aplasia. However, said that agenesis and aplasia are difficult to distinguish from each other both clinically and pathologically, in the end, they are quite often used in the same sense. Lung hypoplasia may be part of the oligohydramnios sequence (aka "Potter sequence") but also part of multiple congenital anomalies (MCA)-associated syndromes. Partial or total hypoplasia may be encountered more often with or without congenital heart disease. The Askenazi-Perlman criteria may be beneficial for the diagnosis of lung hypoplasia. These authors suggest the following guidelines for the determination of pulmonary hypoplasia (LH). Lung weight (LW)/body weight (BW) ratio <0.009, LH very likely, and the radial alveolar count (RAC) are not obligatory to perform. If LW/BW ratio is 0.010-0.012, LH is probable, and RAC is indicated for confirmation of diagnosis. If LW/BW ratio is 0.013-0.017, LH is possible, and RAC is judicious and prudent to perform. If LW/BW ratio >0.018, LH is unlikely. In this setting, RAC may not contribute. Where RAC is estimated, a value <75% of the mean standard value (equivalent to 43% of cubed value) for that laboratory probably indicates LH.

The acronym CCAM for congenital cystic adenomatoid malformation was in use for a while. Ultimately, it has been changed with CPAM for congenital pulmonary adenomatoid malformation, but CCAM is often still in use in the medical literature. CCAM Apart from types II and probably IV, CCAM/ CPAM have a terrible prognosis, and except for type II, CCAM/CPAM present in newborns. The differential diagnosis of these lesions from other neonatal lesions is crucial for the correct management of these cystic lesions. Simple foregut cysts need to be differentiated from CPAM I, and the latter has polypoidal infolds and rows of mucous cells. A bronchogenic cyst needs also to be distinguished from CPAM I, and the latter has no cartilage and mural mucus glands that can be found in bronchogenic cysts. CPAM IV needs to be separated from PPB particularly the well-differentiated PPB type or type I. This differential diagnosis may also be impossible or may require multidisciplinary team meetings or clinicopathologic conferences. The cystic mesenchymal hamartoma has a mesenchymal cambium layer, which is not present in CPAM. Finally, except type 0, CPAM has a pulmonary arterial blood supply, bronchial tree communication, and presence of normal alveoli, all features important in the differential diagnosis with sequestration.

Congenital Lobar Emphysema (CLE) is designated as sudden progressive RDS (respiratory distress syndrome) in young children. CLE usually affects the upper lobe or right middle lobe and there is massive overdistention of airways without tissue destruction (DDX: Lung emphysema of the adult). CLE is part of the CPAM spectrum including CCAM/CPAM and BPS other than CLE.

Lung development may be affected by upper respiratory tract malformations of the trachea and primary bronchi. Tracheal and bronchial anomalies (atresia, stenosis, and tracheoesophageal fistula) are significant to diagnose either during the intrauterine life or after birth, because they may be life-threatening conditions. Atresia (Greek ά-"not" and τρῆσις "hole") is the medical condition in which an aperture (orificium) or transition (channel, tube) in the body is absent or closed, while stenosis (Greek στένωσις derives from στενός "narrow") is an abnormal narrowing or contraction of a body orifice or passage.

The laryngeal web is an incomplete recanalization of the larynx that should take place during the 10th week of embryogenesis. A membranous network may be visualized at the level of the vocal cords with consequent sub-obstruction of the airways.

Tracheoesophageal fistula (TEF) represents an incomplete division of the first gastrointestinal tract or foregut into digestive and respiratory portions. There are five different types of TEF with differently associated pathology. TEF I is focal esophageal atresia consisting of proximal esophagus ending as a blind pouch and evidencing dilation and distal esophagus arising from trachea just above bifurcation (85%). Both esophageal segments characterize TEF II and are blind pouches (8%). Both complete trachea and esophagus characterizes TEF III but remains present a singular connection at the level of tracheal bifurcation (4%). TEF IV is categorized by a proximal esophagus, which connects to the trachea at the level of bifurcation, while the distal portion of the esophagus arises as a blind pouch. Finally, TEF V shows that both proximal and distal esophageal segments communicate with the trachea. The communication of the trachea with the esophagus is a condition that may allow some gastric juice to violate into airways with consequent aspiration pneumonia, which may remain silent for a while. The use of bronchoalveolar lavage with mandatory Oil Red O (ORO) staining of the cellularity may disclose alveolar macrophages filled with red vacuoles and suggest that aspiration pneumonia did occur. About the ORO staining, vide infra.

TEF may usually be associated with some tracheal stenosis or tracheal atresia, although they are quite rare.

Sequestration means segregate or seizure something by law, and pulmonary sequestration is partial or complete segregation or separation of a portion of a lobe from the "surrounding" lung where nonfunctioning pulmonary tissue is separated from the rest of the parenchyma and supplied with blood from often an artery from systemic circulation due to an abnormal budding of the primitive foregut ( Fig. 2.6 ). Another medical condition in which we use the sequestration terminology is sequestrum, which is defined as a fragment of bone or other dead tissue that has separated from the "mother" organ during necrosis,

• DEF: Congenital respiratory anomaly consisting of a portion of nonfunctioning normal lung tissue being excluded by the pulmonary arterial blood supply but receiving arterial blood supply from the systemic circulation and diagnosable in utero by prenatal ultrasound. • SYN: Bronchopulmonary sequestrum.

• EPI: 1-5% of all congenital pulmonary manifestations. • CLI: Asymptomatic→persistent dry cough.

All sequestrations have systemic blood supply from the aorta and not from pulmonary arteries and no connection to tracheobronchial tree or airway system. In 1/5 cases there is CPAM-like histology. The sequestration is subclassified as intralobar if the sequestered portion is enclosed within the pleura of the rest of the lung and extralobar if the sequestered portion is separated from the pleura of the rest of the lung. The blood supply of 75% of pulmonary sequestrations arises from the aorta (thoracic or abdominal), while the remaining 25% of lung sequestrations receive their blood from different sources (subclavian, intercostal, pulmonary, pericardiophrenic, innominate, internal mammary, celiac, splenic, or renal arteries). Intralobar sequestrations may be acquired or congenital, but extralobar is only innate. The usual location of the ILS is the posterior segment of the left lower lobe. ELSassociated congenital anomalies include congenital cystic adenomatoid malformation, congenital diaphragmatic hernia (defect), vertebral anomalies, lung hypoplasia, and colonic duplication (LLL, left lower lobe; RLL, right lower lobe).

Generally, the ILS has the arterial blood supply from the lower thoracic aorta or upper abdominal aorta and the venous drainage to the left atrium via pulmonary veins establishing a left to right shunt. In the medical literature, abnormal connections to the vena cava, azygous vein, or right atrium have been described as well. The ILS may become infected when microorganisms migrate through the "Pores of Kohn" or if the sequestration is incomplete. Commonly, the ELS arterial supply is an aberrant blood vessel of the aorta, while its venous drainage is directed to the right atrium, vena cava, or azygous systems. The ELS rarely gets infected because it is enveloped in its pleural sac. Imaging was associated with an invasive arteriogram showing the systemic blood supply, but new noninvasive techniques are now preferred (e.g., CT scan or MRI). Chest radio-graph shows a uniformly dense mass within the thoracic cavity or pulmonary parenchyma. Recurrent pulmonary infections may lead to having cystic change or cystic areas within the mass. Air-fluid levels due to bronchial communication can also be observed. Ultrasound displays an echogenic homogeneous mass with regular or irregular borders and a more solid or more cystic appearance, and Doppler studies may demonstrate the characteristic aberrant systemic artery. CT scan can show a solid mass that may be homogeneous or heterogeneous with or without cystic change. Usually, there are emphysematous changes at the margin of the lesion, and the CT scan has an overall 90% accuracy to identify pulmonary sequestrations. CT scans may be performed with multiplanar and 3D reconstructions. Contrast-enhanced MRI and T1-weighed spin-echo images may help in the diagnosis of lung sequestrations, although sharper images may be reached better with CT than MRI. There are eight significant complications for sequestrations, including aspergillosis, bleeding, bronchiectasis, chronic infection, leftright shunt, neoplastic degeneration of epithelial type (squamous cell carcinoma of the lung), neoplastic degeneration of neuroendocrine type (bronchial carcinoid), and tuberculosis.

Treatment of the lung sequestration is surgical with the removal of the lung tissue that may show pneumonia. It may be essential to take some swabs from the resection site or at the time the pathologist receives the specimen for the identification of the microorganism. If the fetus is diagnosed with lung sequestration, the Harrison catheter shunt may be used in case drainage of the fluid collection is mandatory. Fetal laser ablation procedure may also be used in some settings. In Scimitar syndrome, cysts in the hypoplastic lung are associated with the absent pulmonary blood vessel. The congenital pulmonary venolobar syndrome (aka Scimitar syndrome), originally described by Catherine Neill in 1960, is a rare congenital heart defect individualized by an anomalous venous return from the right lung draining into the systemic veins, rather than directly to the left atrium. This abnormal drainage creates a curved shadow on chest x-ray resembling a scimitar (Neill et al. 1960 ). Hydatid's Echinococcus granulosus (Echinococcosis) (Fig. 2.7) is an important differential diagnosis in pediatrics.

In 1777, Huber provides the first description of an aberrant systemic artery supplying the lung publishing his findings in a Swiss medical journal (Huber, 1777) . In 1946, the concept of "sequestration" was described by Pryce, but this lexicon could not outline all variants of sequestration, and the concept of a "sequestration spectrum" came forward properly in (Sade et al. 1974 ). Ten years later, the "sequestration concept" was reviewed, and the importance of the venous drainage was emphasized. This concept led to the Clements' "wheel theory," of whom came forth the term "pulmonary malinosculation" (mal-in osculum, a Latin word for "small mouth", ōs "mouth" + -culum, neuter form of -culus, which is the suffix forming a diminutive form of a word) (Clements and Warner, 1987) . Malinosculation is the presence of abnormal communications by small opening or anastomoses. In 2007, Lee et al. proposed the "haphazard theory" to better substantiate this concept describing seven types of pulmonary malinosculation. Typically, pulmonary AV malformations are congenital lesions caused by abnormal development of capillaries. Their etiology is not completely understood, and some genetic/epigenetic factors are thought to play a role in the formation of disease. Lee et al. based their observation on whether the abnormal communication involved the bronchi, arteries of the lungs, or veins of the lungs in isolation or different combinations. Lee et al. schema consists of dividing bronchopulmonary vascular malformations systematically into seven subcategories (types A-G) using the "malinosculation theory." Different surgeries have been reported, including ligation of the anomalous artery and lobectomy, surgical ligation of the anomalous artery only without lobectomy, and disconnection of the anomalous artery from the aorta and anastomosing it to the pulmonary artery. Pulmonary malinosculation is a very intriguing investigative field, which is based on the malinosculation term. Stedman's Medical Dictionary defines malinosculation as the creation of abnormal communications using openings or anastomoses, applied 

There are lung diseases of infantile and/or pediatric onset with surface epithelial involvement and no direct interstitial involvement, but "adult" interstitial lung diseases may also occur in the adolescent and youth and need to be considered when evaluating a patient with respiratory problems according to age, physical examination, family history, and environmental issues (Box 2.5).

It is crucial to spend some words on surfactant, before dealing with the neonatal respira-tory distress syndrome (NRDS). The surfactant consists of a combination of proteins and lipids, mostly phosphatidylcholine, which are secreted by type II pneumocytes. The four main proteinaceous components of the surfactant are SP-A, SP-B, SP-C, and SP-D. The corresponding genes are SFTPA, SFTPB, SFTPC, and SFTPD. Type II pneumocytes and alveolar macrophages are responsible for clearing the surfactant. SP-B and SP-C are hydrophobic proteins and have been seen playing a critical role in determining the right balance for surfactant tension activity and cellular homeostasis. SP-A and SP-D, encoding for collecting-like molecules, have not associated with pediatric ILDs. Biallelic mutations cause SP-B deficiency with AR-inherited transmission and have been associated with RDS in term neonates. SP-C, which is monoallelic and transmitted in half of the cases as AD and half of the affected patients being sporadic, has been associated with quite a broad spectrum of clinical manifestations, including neonatal RDS, ILD of infancy and childhood, familial pulmonary fibrosis of adulthood, recurrent lung infections, and bronchiectasis. ABCA3 is a lipid transporter associated with lamellar bodies in the pneumocyte type II. Biallelic homozygous mutations or double heterozygous mutations of the ABCA3 gene, cause a deficiency of the protein, which is responsible for an early-onset RDS similar to SP-B deficiency but also observed not too rarely in adolescents with ILDs.

TTF-1 is a nuclear factor, which plays an essential role in lung, thyroid, and CNS maturation. TTF-1 plays a significant role in the expression of SP-B, SP-C, and ABCA3. Mutations or deletions that cause haploinsufficiency of the gene encoding TTF-1, i.e., NKX2.1, have been found leading to variable combinations of respiratory failure, hypothyroidism, and brain-related disturbances, such as hypopituitarism and choreoathetosis, which is an extrapyramidal disorder characterized by combined involuntary movements of chorea (irregular contractions of migrating type) and athetosis (twisting and squirming). Haploinsufficiency is a genetic condition in which one copy of a gene is deleted or inactivated, while the remaining functional copy of the gene is present but remains inadequate to translate a sufficient gene product unarguably needed to preserve the normal function of the gene. The function of the surfactant is dual, including the function (1) to decrease the alveolar surface tension preventing the end-expiratory alveolar collapse and the function (2) to increase the armamentarium for an efficient anti-infectious defense. Gene mutations of SFTPA, SFTPB, SFTPC, and SFTPD are responsible for quantitative and qualitative alterations of intra-alveolar surfactant, ultimately leading to ineffective surfactant and abnormal clearance. The toxicity of the non-secreted proteins targets cells involved in its production. Granulocyte-macrophage colonystimulating factor (GM-CSF) is a critical cytokine in the pathophysiology of abnormal surfactant clearance. GM-CSF has two subunits, alpha (α) and beta (β), which are coded by the respective genes, CSF2RA and CSF2RB. Mutations in these genes prevent GM-CSF signaling. GM-CSF is a growth factor for granulocytes and monocytes, stimulating differentiation, proliferation, and cell survival of myeloid cells, monocytes, neutrophils, and dendritic cells. Moreover, antibodies against GM-CSF can impair surfactant clearance due to hyporeactive ( which dipalmitoyl-phosphatidylcholine (DPPC) is ~60% and phosphatidylglycerol/ethanolamine/ inositol is ~20%. Moreover, there are 10% neutral lipids (e.g., cholesterol, which is the most represented neutral lipid compound), 10% surfactant-associated proteins (SP-A, SP-B, SP-C, and SP-D), and <1% infitesimal traces of other substances. SP-A (SFTPA) and SP-D (SFTPD) are hydrophilic proteins with CHO recognition domains that allow them to coat bacteria and viruses promoting phagocytosis by macrophages, while SP-B (SFTPB) and SP-C (SFTPC) are hydrophobic proteins that increase the rate the surfactant can spread over the surface. Surfactant synthesis is modulated by a variety of hormones and growth factors, including cortisol, insulin, prolactin, thyroxine, and TGF-β. The knowledge of factors and clinical scenarios potentially impairing surfactant synthesis is vital for both pediatrician and pathologist.

• DEF: Multifactorial syndrome at neonatal onset with lower respiratory tract involvement due to absolute or relative, mostly global, surfactant deficiency and guarded prognosis if no treatment is undertaken ( Fig. 2 .8). • EPG: (Causal/concausal) -hyaline membrane disease (HMD) of the preterm and appropriate for gestational age (AGA), intrauterine hypoxia (e.g., intrauterine pericervical cord coiling), aspiration of blood/amniotic fluid, fetal head (skull) injury during delivery, and excessive or inappropriate sedation of the mother. • HMD: Preterm/AGA, ♂ > ♀, maternal diabetes, C-section mode of delivery, deficiency of pulmonary surfactant (lecithin or DPPC, phosphatidylglycerol, hydrophilic SP-A and SP-D, hydrophobic SP-B and SP-C). • DDX: The differential diagnosis of RDS is meconium/amniotic fluid aspiration syndrome (MAS); HMD; bronchopulmonary dysplasia (BPD); congenital heart disease (CHD), especially cyanotic; congenital diaphragmatic defect (CDD); congenital pneumonia; pulmonary immaturity; positive end-expiratory pressure (PEEP)-related RD ("respiratory therapy-related); and transient tachypnea of the newborn (TTN).

The examination of the lungs is critical.

• GRO: Airless, and red-purple solid lungs prone to sink in water. • CLM: Atelectasis with poorly developed alveoli + hyaline membranes (fibrin (PAS+) and cell debris chiefly from necrotic type II pneumocytes. • TEM: The precise histological structure of the alveolar wall in HMD has been studied by Lauweryns (1965) using the electron microscope. The alveolo-capillary membrane is made up of three continuous and distinct layers: (1) external, the alveolar cells, (2) the interstitium, and (3) the capillary endothelium (flat endothelial cells). The hyaline membranes as seen by conventional microscopy lie directly upon the reticular fibers of the alveoli and alveolar ducts. This finding confirms the necrosis of the epithelial portion of the wall, and this hypothesis is reinforced by the remarkable and incontrovertible discovery in the same pulmonary tissue sections of areas with hyaline membranes and absent epithelium, along with normal alveoli with an epithelial lining but no hyaline membranes O 2 toxicity: Retrolental fibroplasia (or retinopathy of prematurity) due to VEGF changes (initially decreased in hyper-O 2 status and then increased in hypo-O 2 status as room air ventilation) and bronchopulmonary dysplasia (vide infra).

Bronchopulmonary Dysplasia (OBPD and NBPD)

"Old"/classical type is defined by airway epithelial hyperplasia, squamous metaplasia, alveolar wall thickening, and peribronchial as well as interstitial fibrosis, while the "new" type shows a decrease of alveolar septation (i.e., large alveolar structures, which seem "simplified") and dysmorphic capillary configuration. New BPD infants are less than 30 weeks' gestation (usually ≤28 weeks) with BW <1250 g and an ♂ > ♀ predominance. The lower the weeks' gestational age is, the higher the risk is to develop the new BPD. Currently, this pathology occurs more than before and the reason may also lie to the increased survival in very low birth weight (VLBW) babies. Worldwide the prevalence of BPD is also increased ( Fig. 2.8) . Substantially, the severity of the new BPD is less than the old BPD.

Atelectasis arises from two Greek words combined (ἀτελής, incomplete, and ἔκτασις, extension) and is a complete or partial collapse of a lung or lung lobe developing when the alveoli within the lung become deflated.

• Neonatal atelectasis: Incomplete expansion of the lung • Acquired atelectasis: The collapse of the lung structure of the previously inflated organ Acquired atelectasis may occur for several causes. In the case of resorption (obstruction), it is due to complete blockage of an airway (bronchial asthma, chronic bronchitis, bronchiectasis, post-op surgical immobilization, and foreign body aspiration). In the case of compression, the atelectasis is due to a partial/complete filling of the pleural cavity (exudate, tumor, blood, air). In the case of a contraction, it is expected to have local/generalized fibrotic changes that occur in the lung/pleura preventing full expansion. Some authors prefer using the term "dystelectasis" instead of the most commonly used term of a-telectasis for acquired atelectasis that has not been present at the time of birth, but this word seems to be more diffuse in some European countries than worldwide. Substantially, resorption is a process of lung volume decrease, which is linked to obstruction of the full type of an airway directing to a lung section and may be due to bronchial asthma, chronic bronchitis, bronchiectasis, post-surgery, or foreign body aspiration (FBA)-associated bronchial ways obstruction. Compression is a process of lung volume decrease due to partial or complete filling of the pleural cavity by solid (e.g., tumor), liquid (e.g., exudate or blood), or air (e.g., pneumothorax). Finally, contraction is a process of lung volume decrease due to local or generalized fibrotic changes of the lung parenchyma or of the pleura preventing full expansion of the lung. These concepts are essential to understand the radiograph or CT of the lung and later to understand the basis for the chronic obstructive pulmonary disease of the adult.

Cystic fibrosis is a quite frequent disease with multivisceral involvement that both the medical student and the physician come across often both during the years of medical studies since biology and during the medical practice across several specializations.

• DEF: Progressive, a genetic disease that causes persistent lung infections with progressive respiratory failure. • SYN: Mucoviscidosis.

• GEN: AR, carrier: 1/20 (white Caucasians), CFTR gene (7q22-7q31) with variable penetrance. • EPG: Gene mutations (mostly Delta Phe508 or ΔP508) hampering the correct function of the gene product, which is a Cl − transporter resulting in defective anion (X − ) transport, particularly Cl − and HCO 3 − , with subsequent abnormal H 2 O movement through the plasmatic membrane. • CLI:

1. Lung: ↓ Cl − transport into lumen results in viscous secretions, which plug airways and determine progressively lung disturbed function aiming to usual interstitial pneumonia (UIP) 2. Pancreas: Pancreas insufficiency 3. Liver: Cholestatic liver disease 4. Testis: Infertility 5. Skin: Oversaturated (hypersaline) sweat due to absent (somewhat rare) or ↓Cl − resorption from secretions -sweat high in NaCl! • TRT: Symptomatic until lung transplantation.

• PGN: Currently, CF remains one of the main reasons for lung transplantation in the young population. There is also an increased risk for lung infections by Staphylococcus and Pseudomonas spp. These infections are not little things but may be often fatal.

There are lung diseases at infantile and pediatric onset with surface epithelial involvement and direct interstitial involvement. Also, adult interstitial lung diseases may also occur in the adolescent and youth. They need to be engaged into account according to the family history and environmental connection and exposure (Box 2.6).

Interstitial lung disease associated with a diffuse lung development may have different patterns that need to be recognized by light micros-copy. However, immunology plays a significant role in pulmonology. Thus, concepts of innate versus adaptive immunity should be evident in mind investigating a pulmonary pathology. Central lymphoid organs constitute tissues of the immune system (e.g., thymus), peripheral lymphoid organs (e.g., BALT, i.e., bronchial mucosaassociated lymphatic tissue), and lymphocytes of the circulating blood or fluids. HLA (human leukocyte antigens) and disease association are well known (e.g., B27, DR3, DR4, etc.). Cytokines of innate immunity are TNF, IL-1, IL-12, type I IFNs, IFN-γ, and chemokines, while the cytokines of adaptive immunity are IL-2, IL-4, IL5, IL-17, and IFN-γ. Subsets of T H cells comprise T H1 , which produce IFN-γ. IFN-γ is responsible for MΦ activation and IgG production. Another subset comprise T H2 , which secrete IL-4, IL-5, and IL-13 and are accountable for the recruitment of eosinophils with IgE involvement in the process. Finally, the T H17 subset produce IL-17, IL-22, and chemokines, which are responsible for PMN and monocytes/MΦ recruitment. T H1 is vital for host defense against intracellular microbes, while T H2 is central for host defense against helminths, and T H17 is crucial for fighting extracellular bacteria and fungi. Humoral immunity is played by naive B lymphocytes recognizing antigens and under the influence of T H cell subsets as well as other stimuli. During the humoral immu- nity, the B lymphocytes are activated to proliferate and differentiate into Ab-secreting cells, i.e., plasma cells. Some of the activated B lymphocyte undergo heavy chain class switching and affinity maturation, and some become the cell population subset, known as memory cells. Hypersensitivity reactions may be life-threatening. They include allergenassociated, cellular-associated, Ig-associated, and delayed-associated reactions.

In a children's hospital clinic-pathologic conferences or multiteam disciplinary meetings, by the discussion of a child with respiratory disorders of specific gravity, it is often discussed the necessity to gather some lung tissue for histology and molecular studies. It is usually a discussion if it is convenient or appropriate to perform an open lung biopsy or a transbronchial lung biopsy. About the lung biopsy, timing is crucial (e.g., immunosuppression), and late-stage biopsy may be inconclusive. The decision is ultimately individualized. Transbronchial biopsy is feasible in the setting of eosinophilic pneumonia, lymph-angioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis, sarcoidosis, vasculitis, malignancy, and lung transplantation. The lung biopsy interpretation relies on the pathology of the architecture (airspace, interstitium, mixed), distribution of the process (diffuse, mono-/bilaterality, severity variation), pattern (specificity, randomness), location (bronchiolar/bronchocentric), and lymphovascular involvement.

Desquamative interstitial pneumonia (DIP) is characterized by a diffuse alveolar presence of macrophages, monotonous, uniform pattern, limited thickening alveolar walls, and no alveolar debris/fibrin. Nonspecific interstitial pneumonia (NSIP) is a diffuse interstitial process, uniform in the stage of pathologic changes with mild inflammatory and fibrotic interstitial changes, no intraalveolar exudate, and remarkably better prognosis than usual interstitial pneumonia/pneumonitis (UIP). Indeed, UIP is characterized by the heterogeneity of the pathologic changes with often confounding hyaline membranes in the early stages, diffuse alveolitis (lymphocytes, macrophages) and lymphoid aggregates, thickening of alveolar walls (↑ fibroblasts, smooth muscle, and collagen), and fibroblastic foci in the interstitium in all stages. The acute interstitial pneumonia (AIP) is categorized as diffuse alveolar damage, and the pathologic changes are uniform, focal hyaline membranes, mild alveolitis (lymphocytes, macrophages), some thickening of alveolar walls (diffuse proliferation of fibroblasts), but no obvious collagen fibrosis. Pathologic changes leading to end-stage lung fibrosis (honeycomb lung) are interstitial pneumonia, diffuse alveolar damage (DAD), inorganic dust exposure, interstitial granulomatous disease (infections, extrinsic allergic alveolitis, sarcoidosis, berylliosis), Langerhans cell histiocytosis, and prolonged or untreated severe GERD. In Box 2.7 are presented the salient features of the ILD of adult type.

• DEF: Primary developmental lung abnormality with a severe form of hypoplasia and abnormal lung architecture with acini with incomplete formation of airspaces. It repre-

sents an arrest of growth of the lung bud with architecture like ("stopped to") the pseudoglandular stage of development. • EPI: Very rare, ♂ < ♀.

• EPG: Disturbance of the epithelialmesenchymal interaction with genetic linkage including TBX4 or T-box transcription factor mutations, de novo missense mutation p.E86Q (c.256G > C) in DNA binding, homozygous FGFR2 mutations in ectrodactyly-pulmonary acinar dysplasia, of which a missense mutation may be found in the IgIII domain (D3) (p.R255Q). • CLI: Associated congenital defects are not typical (e.g., right-sided aortic arch, renal dysplasia) ± pregnancy complicated by chronic placental abruption with fetal adrenal hemorrhage and cerebral infarcts of the baby. • PGN: Uniformly lethal.

• DEF: Primary developmental lung abnormality with the incomplete acinar development of the pulmonary architecture with an arrest of growth of the lung bud at the level of the saccular stage of lung development. • EPI: Rare disease, usually term infants.

• EPG: Genetic etiology unknown. • PGN: Longer survival than acinar dysplasia.

With/Without Misalignment of Pulmonary Veins (ACD/MPV) 

• DEF: Multifactorial syndrome at neonatal onset with lower respiratory tract involvement and considered to be reduced formation of airspaces and alveoli at the periphery of the lung. Lung pathology in Down syndrome is typified by small size with ↓ of lung volume and ↓ rate of airway generation, RACs, total number of alveoli, and alveolar surface area and ↑ mean linear intercept, large alveoli and alveolar ducts with a double capillary layer of the alveolar wall ("double alveolar capillary network"), alveolar hypoplasia with deficiency of the elastic fibers in the alveolar walls, and subpleural cysts (Ø: 0.1-0.2 cm) with some fibrosis in the intercystic spaces.

Moreover, infants with Down syndrome and structural CHD may develop earlier and progress more rapidly to irreversible pulmonary vascular changes than infants without Down syndrome. The more rapid development of pulmonary hypertension in infants with Down syndrome is probably due to some specific reasons, including chronic upper airway obstruction (e.g., tracheomalacia and tracheal bronchus "malacia"), recurrent pulmonary infection, and alveolar hypoventilation. The development of progressive pulmonary hypertension (PPHN) in Down syndrome is associated with failure of neonatal pulmonary vascular remodeling in such infants. Criteria of PPHN include hypoxemia refractory to O 2 therapy or lung recruitment strategies, which are achieved by conventional ventilation and high positive end-expiratory pressure (PEEP) initially and now replaced by high-frequency oscillatory ventilation later, as well as the presence of extrapulmonary shunt at atrial or ductal level in the lack of severe pulmonary parenchymal disease. Early development of the pulmonary vascular disease is seen in 1/10 to almost all children with Down syndrome and affected with structural CHD. RACs are usually evaluated by dropping a perpendicular line from 

Other than trisomy 21 syndrome, there are some disorders with either chromosomal aberration or microdeletions of the genome that may show interstitial lung disease in infancy and child-hood. Microdeletions with ILD include (but are not limited) thrombocytopenia-absent radius syndrome and 1q21.1 deletion, Prader-Willi syndrome due to chromosome 15q11.2-14 deletion, and the proximal chromosome 14q microdeletion syndrome.

• DEF: Interstitial lung disease with chronic hypoxemia, concomitant persistent tachypnea, and characteristic appearance on CT imaging plus hyperplasia of neuroendocrine cells (pathology) in the lungs of infants ( Fig. 2 .10). • EPI: Pulmonary disorder affecting infants less than 2 years of age but unknown detailed epidemiologic data. 

The glycogen is a component frequently encountered in lung tissue of fetal age. Pulmonary inter-stitial glycogenosis (PIG) is not a life-threatening disorder but started to play a significant role in PICU in the last couple of decades.

• DEF: Congenital respiratory syndrome occurring at neonatal age with lower respiratory tract involvement due to absolute or relative, mostly global, deficiency of enzymes related to glycogen metabolism in interstitial fibroblasts and variably associated with congenital heart disease and PPHN. • CLI: Variable clinical pictures ranging from mild disturbances of the lung function through respiratory failure. • CLM: Presence of glycogen in the interstitium better highlighted using periodic acid Schiff (PAS) staining ( Fig. 2 .11). • TEM: Primitive interstitial cells with numerous monoparticulate glycogen and few organelles, but no abnormal glycogen. • TRT: Corticosteroid-responsive, due to the induction and acceleration of the interstitial cell maturation. • PGN: Good.

Multifactorial syndrome at neonatal onset with lower respiratory tract involvement due to absolute or relative, mostly diffuse, deficiency of factors playing a critical role in surfactant tension dynamic properties. The SFTPB gene indel a b

Pulmonary interstitial glycogenosis (PIG) showing a thickening of the alveolar septs (a, H&E, 400×), which is also partly Periodic Acid Schiff-positive (b, PAS, 400×) g.1549C > GAA (121ins2) is responsible for about 60% of the mutant alleles underlying complete surfactant protein B deficiency, which shows AR inheritance. Somatic recombination and about 50% spontaneous mutation account for the monogenic disorder, which is autosomal dominantly inherited. ATP-binding cassette, subfamily A, member 3 (ABCA3) is characterized by AR inheritance and uniparental disomy (UPD), while the NK2 homeobox 1 (NKX2-1) monogenic cause of surfactant deficiency shows an AD inheritance and harbors about 50% spontaneous mutations. In UPD, both copies of a chromosome pair or portions of a chromosome pair are inherited from a single parent with heterodisomy (inheritance of two homologous chromosomes from the same parent) or isodisomy (inheritance of two copies of the same chromosome from the same parent).

• DEF: Surfactant dysfunction disorder encompassing a variety of mutations involving the gene that encodes surfactant protein B (SFTPB). • CLM: There is widened interstitial space with fibroblast proliferation, the arrest of the acinar development with a remarkable decrease of the number of alveoli, cuboid metaplasia of the alveolar epithelium, and alveolar lumen filled with eosinophilic proteinaceous material, which contains macrophages and desquamated epithelial cells (DIP-like or PAP-like pattern according to different authors who have intensely studied this entity; DIP, desquamative interstitial pneumonia/pneumonitis; PAP, pulomnary alveolar proteinosis). • TEM: Large cytoplasmic inclusions with irregularly arranged lamellae associated with membranous and vesicular structures.

• DEF: Surfactant dysfunction disorder encompassing a variety of mutations involving the gene that encodes surfactant protein C (SFTPC) with the phenotype caused by aberrant surfactant protein folding, decreased endogenous SP-C secretion, ER stress, and apoptosis of alveolar epithelial cells.

• CLI: The lung disease associated with SFTPC mutations is characterized by marked phenotypic heterogeneity with a range of severe respiratory distress in infants to NSIP and UIP/idiopathic pulmonary fibrosis (IPF) in older adults. • CLM: There is DAD, interstitial thickening with fibroblast proliferation and collagen deposition, numerous foamy macrophages and granular lipoprotein material in the alveolar lumina, and type II pneumocyte hyperplasia (AEC2) corresponding to DIP-like or PAP-like patterns according to the authors. Multiple fibrosis foci have also been encountered. • TEM: ER stress and apoptosis of alveolar epithelial cells.

• DEF: Surfactant dysfunction disorder encompassing a variety of mutations involving the gene that encodes ATP-binding cassette transporter A3 (ABCA3). • CLM: Patterns with DIP-or PAP-like appearance like either SP-B or SP-C deficiencies. • TEM: Abnormal lamellar body (LB) with tightly packed concentric membranes and a cluster of electron-dense material ("fried eggs").

• DEF: AR inherited disease caused by an intrinsic defect of cationic amino acid transport. LIP is etiologically associated with mutations of the SLC7A7 gene, the protein of which is located at the membrane of epithelial cells in the intestine and kidney. The expression of SLC7A7 is a target of GM-CSF that may explain the reduced activities of the alveolar macrophages and peripheral blood monocytes of patients harboring this gene defect. • CLI: Most patients present in infancy with failure to thrive, growth retardation, protein aversion, muscular hypotonia, hepatosplenomegaly, and osteoporosis. Lysinuric protein intolerance is diagnosed either by gene sequencing or by the presence of excessive amounts of dibasic amino acids (Arginine, Lysine, Ornithine) in the urine, particularly following protein ingestion (e.g., red meat ingestion-based test). • CT/MRI: Patients who developed a fatal respiratory insufficiency are usually children younger than 15 years of age, and adult patients with ILD on CT scans of the chest show inter-and intralobular septal thickening and subpleural cysts, but only a few are symptomatic.

A combined genetic and morphologic approach to SF deficiency disorders includes intradepartmental and extra-institutional consultation, whole blood or a buccal swab from affected infant ± parents for further studies, molecular biology investigation targeting the hotspot mutations and genes, sequencing of the entire exomes, and the lung biopsy. The lung tissue biopsy received at the Department of Pathology should be processed according to the ChILD guidelines. Medical consideration in infants with surfactant deficiency includes genetic diagnosis essential to inform the choice of medical interventions, evaluation of extrapulmonary organ dysfunction, unavoidable CNS-hypoxia changes and CNS anomalies, recurrence risk in siblings, and ability to be transferred to a lung transplantation center. Family considerations include progression of lung failure, adequate provision of information about the diagnosis and prognosis, and discussion of compassionate care in selected cases unsuitable for lung transplantation (e.g., numerous CNS-hypoxia-related changes, multiple congenital anomalies).

• DEF: Lung disease with a restrictive ventilatory defect (↓ lung volume and capacity, hypoxemia with ↑P(A-a) O 2 ) characterized by the accumulation of surfactant-like (lipo-)proteinaceous material in the alveoli due to abnormal homeostasis or clearance by the alveolar MΦ.

• SYN: Pulmonary alveolar lipoproteinosis.

• EPI: Rare, 20-50 years, ♂:♀ = 2:1.

• EPG: Abnormal surfactant homeostasis due to defective chemotaxis, phagocytosis, and phagolysosomal fusion of alveolar MΦ with broad pathogenic categories. • CLI: In children, the presentation may be pulmonary (e.g., cyanosis) or extrapulmonary with diarrhea, vomiting, and failure to thrive, while in adults slowly progressive pulmonary infiltrates, dyspnea, cough, sputum, and fever are more typical, but 1/3 of patients may be asymptomatic. • There is ↑ P(A-a) O 2 with shunting of blood from right to left through an entire pulmonary capillary bed (sine qua non conditio), differently from poorly ventilated alveoli filled with material. If PAP presents in infants <1 year, there is an association with thymic alymphoplasia. • CXR: Airspace consolidation ("bat's wings pattern" = bilateral central symmetrical opacities with costophrenic and apical sparing) to diffuse poorly delimited small acinar nodules with ground-glass opacification ("military pattern"). The "bat's wings pattern" is typical in adults, while the "military pattern" with diffuse opacities is mostly common in children. • HCT: Airspace consolidation ("crazy paving pattern") ± thickening of interlobular septs (ILS). • LAB: ↑GM-CSF, ↑LDH, ↑KL6, ↑SP-A, ↑SP-D ± ↑tumor markers, depending on the type. • DGN: BAL + HCT (± TEM on BAL) ± TBB/ OLB. If either a transbronchial biopsy (TBB) or open lung biopsy (OLB) is performed, findings may be inconclusive, because of the patchiness of the alveolar process. • GRO: Patchy areas of yellow parenchymal consolidation with some oily material exuding following cutting the lung (post-transplantation, autopsy) or OLB, which is rarely required. • CLM: (1) ± (2) features, including:

1

material with normal interstitial pulmonary architecture ≠ mucus, which is PAS(+)/DPAS(−)/AB(+) 2. Septal thickening (pauci-cellular = edema, cellular = lymphocytic infiltration) • BAL: "Milky Fluid", due to a basophilic granular extracellular deposition with some enlarged foamy MΦ and cellular debris on cytology. • TEM: Abundant cellular debris and LBs ± sparse tubular myelin structures. • DDX: Airspace consolidation ("crazy paving pattern") ± thickening of ILS may raise the differential of lipid pneumonia or bronchoalveolar carcinoma (BAC) or other ILDs. • TRT: Whole lung lavage, GM-CSF, rituximab (a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B lymphocytes), plasmapheresis, targeting the underlying disorder, e.g., cancer. • PGN: Excellent (25%, spontaneous resolution), but it depends exquisitely on the pathogenic type.

PAP categories include a congenital type (~2%, neonates or also known as "chronic pneumonitis of infancy" with inherent SF-abnormality), a secondary type (~8%, children, and adults, due to anti-granulocyte-macrophage colony-stimulating factor (anti-GM-CSF) antibodies or other precipitating diseases, including hematological neoplasms, immunodeficiency, immunosuppression, and pneumoconiosis), and an idiopathic type (~90%, adults/youth or acquired).

PAP has been reported following inhalation of both mineral particles (silica, talc, cement, kaolin), metals (aluminum, titanium, indium), and organic particles (fibers of cellulose). The massive inhalation of silica is also called silicoproteinosis. In summary, genetic PAP includes mutations in the genes, SFTB, SFTC, ATPbinding cassette 3 (ABCA3), NK2 homeobox 1 (NKX2-1), and CSFRA and CSFRB. Lung histology of patients with mutations of SFTB, SFTC, ABCA3, NKX2-1 is remarkably similar showing varying degrees of thickening of the alveolar interstitium and remodeling of the alveolar epithelium. There is type II cell hyperplasia in addition to the intra-alveolar accumulation of eosinophilic, PAS (+) lipo-proteinaceous granular material, while in patients with CSFRA and CSFRB mutations, there is the relative integrity of alveolar architecture with only the accumulation being identifiable. CSFRA mutations have been described in children, while CSFRB has been described in both children and adults. As mentioned above, SP-A and SP-D bind to bacteria, viruses, and fungi facilitating the uptake of these microorganisms by the alveolar MΦ. The binding of SP-A and SP-D to the collecting receptor on alveolar MΦ determines an oxidative burst and determines an enhancement of phagocytosis. The lipo-proteinaceous material also acts as a scavenger for free radicals and hereafter impairs the oxidative burst that occurs in the alveolar MΦ during the phagocytosis. Of note, asphyxia may occur in a patient during general anesthesia with alveolar flooding. The PAP-associated risks are asphyxia, emphysema, fibrosis, infection, and pneumothorax. If the patient is scheduled for lung transplantation, a checklist should be filled including number and duration (written documentation) of meetings with parents/guardian about 5-YSR/outcome, no extrapulmonary organ dysfunction, optimization of enteral nutritional status, patient stable enough to be transported to a pediatric lung transplantation center, and the written documentation of the use of HFOV (highfrequency oscillatory ventilation).

As indicated above "adult" interstitial lung disease may be present in the adolescent and young male or female and need to be taken into account according to age, physical examination, family history, and environmental issues.

• DEF: A multifactorial syndrome with common grossly and microscopic sequelae. It is linked to severe acute lung injury (ALI) with acute onset of dyspnea following a known etiologic agent (in the absence of cardiac failure) and potential progression to adult respiratory distress syndrome (ARDS) with severe hypoxemia, a decrease of lung compliance, and a high mortality rate (50%) (Fig. 2.12 ). • SYN: Acute lung injury (ALI), acute interstitial pneumonia (AIP). • EPG: ARDS mnemonic for:

-Aspiration (gastric content), Air embolism, and Amniotic fluid embolism -Radiation-Trauma-Burns (physics) -DIC, Drugs (chemotherapy, heroin), near

Drowning, Dialysis, Dysregulation of metabolic pathways (pancreatitis, uremia, and ingestion of paraquat) -Shock, Sepsis, and Smoke inhalation In determining the etiology of DAD/AIP, clinical history and radiographic imaging are paramount (Box 2.8). DAD is an abnormal (pathologic) respiratory pattern with a multi-etiologic background. In the event of an idiopathic etiology/setting DAD is termed acute interstitial pneumonia, although both names remain often interchangeable, at least for some extent and for most authors and pulmonary specialists. There is a combined endothelial and epithelial injury with bilateral and diffuse lung involvement. Pulmonary capillary wedge pressure (PCWP) represents the measurement of this pressure and is quite diffuse in the medical literature, although balloon occlusion occurs in the pulmonary arteries. Thus, the value obtained at time of the procedure is not indeed equal to the pulmonary capillary pressure in nonoccluded areas. Since the term PCWP is misleading, the term "pulmonary artery occlusion pressure". PCWP ≤18 mmHg excludes cardiogenic causes of lung edema. Nuclear factor kappa-light-chain-enhancer of activated B cells, labeled as NF-κB, is the key molecule. NF-κB is a protein complex found in almost all cell types of animals and is basilar to control DNA transcription. NF-κB is mainly involved in cellular responses to diverse stimuli such as general cellular stress, some cytokines, free radicals, UV irradiation, oxidized LDL, and several antigens of bacteria and viruses. Also, NF-κB plays a key role in regulating the immune response to infection being light chains of kappa-type critical regulators for the formation of Ig. NF-κB dysregulation has been linked to abnormal cellular responses leading to cancer, chronic inflammation, autoimmunity, and septic shock.

↑ NF-κB ⇒ increase of IL1, IL8, and TNF-α ⇒ endothelial cells and PMN activation ⇒ microvascular sequelae with an increase of leukotrienes, platelet activating factor, and other proteases.

• CLI: Abrupt onset of severe, unresponsive arterial hypoxemia + CXR variable from almost normal (beginning) to diffuse bilateral infiltrates (advanced stage). • HCT: In the early phase, lung consolidation developing into bilateral diffuse ground-glass opacities and in the late stage there is cyst formation and honeycombing pattern of diffuse type. • GRO: Heavy, congested solid lungs.

• CLM: Essentially, two stages:

-Exudative (1st week, interstitial and intraalveolar edema, hemorrhage, fibrin deposition, and microthrombi in small blood vessels and capillaries, hyaline membranes (from the 3rd day after insult) and sloughing of alveolar cells with BM denudation. -Proliferative (2nd week, interstitial inflammation and fibroblast proliferation and interstitial fibrosis with organization/ phagocytosis of the hyaline membranes, type II alveolar cells hyperplasia, and reactive atypical squamous metaplasia following bronchiolar damage). Some fragments of the hyaline membranes may remain in the alveolar lumina and are incorporated into the interstitium, and the alveoli are lined by reactive alveolar lining cells with hobnail phenotype. At this time, mitoses as well as marked reactive atypia with enlarged nuclei and prominent nucleoli as well as squamous metaplasia of bronchiolar and adjacent airspaces can be observed. • PGN: Etiology-dependent, lung interstitial fibrosis-dependent, and variable survival rates (6-MSR: ~50%). • TRT: Mechanical ventilation and hemodynamic support are the mainstay of DAD. Critical is the recognition that the fluid is entrapped in the lung by a diffuse fibrin gel that cannot be mobilized by diuresis, and perfusion pressures should be kept with near-normal wedge pressures. Moreover, overdiuresis, which can theoretically deplete intravascular volume and decrease right heart filling pressures, needs to be absolutely avoided.

Hamman-Rich disease: Rapidly progressive, idiopathic form of ALI of young adults with bad PGN (2-MSR: ~50%) that may follow flu or flu-like illness and be characterized by diffuse temporally synchronized and hypocollagenous fibroblast proliferation, proteinaceous exudate, and hyaline membrane deposition.

• DEF: Multifactorial diffuse ILD, temporally uniform and bronchiolo-centric distributed, which is characterized by intra-airspace plugs of granulation tissue and showing filling proliferative, branching or serpiginous, polypoid fibroblastic plugs (Masson bodies) with mild interstitial inflammation, and normal adjacent parenchyma (Figs. 2.13 and 2.14).

• SYN: Bronchiolitis obliterans organizing pneumonia (BOOP). The term "BOOP" was previously known in the literature but it is important to remember that an obliterating bronchiolitis can or cannot be present. • EPI: 6-7 cases per 10 5 hospital admissions at a major teaching hospital in Canada and 1.1 per 10 5 in Iceland, any age, but pediatric cases are quite rare, ♂ = ♀. • EPG: Specific causes of OP need to rule out and differentiated from the cryptogenic form of OP, and medical history/diagnostic tasks will include questions and laboratory tests to exclude infection, toxins, drugs, radiation, and inflammatory bowel disease. When an etiology cannot be identified, the adjective "cryptogenic" is used. • CLI: Subacute onset of dyspnea and cough with a prodromal infectious event of the upper respiratory tract. • HCT: Patchy airspace consolidation and nodules. • CLM: There are airspaces filled with proliferative polypoid fibroblastic plugs (branching or serpiginous) or Masson bodies with lightly stained fibrosis with a myxoid pale-staining matrix rich in mucopolysaccharides and mild interstitial inflammation (lymphocytes, macrophages, plasma cells, and neutrophils) of terminal bronchioles, alveolar ducts, and spaces. Normal adjacent parenchyma but obstructive pneumonia may be seen distally to the fibroblastic plugs. COP may occur as acute exacerbation of UIP, and clinico-pathological correlation is recommended.

Notes: DAD/AIP diffuse alveolar damage, UIP usual interstitial pneumonia, NSIP nonspecific interstitial pneumonia, COP cryptogenic organizing pneumonia, AEP acute eosinophilic pneumonia, HM hyaline membranes. AEP is characterized by numerous eosinophils a b c d is a transmembrane glycoprotein, which is also a member of the immunoglobulin supergene family. CD7 does play a key role in T-cell and T-cell/B-cell interactions during the early stages of lymphoid development, while the CD3 T cell coreceptor is crucial in activating both the cytotoxic T cell and also T helper cells.

• TEM: Type I pneumocyte necrosis (early phase). • DDX: UIP, AIP, AEP.

• UIP: Spatiotemporal heterogeneity, random subpleural scarring, interstitial fibrosis, "honeycomb", fibroblastic foci adjacent to mature collagen with mostly collagenous fibrosis. • AIP: Diffuse hyaline membranes in early stage and potential honeycomb change later. • AEP: Acute inflammation with predominant eosinophils (AEP, acute eosinophilic pneumonia/pneumonitis). • TNT: Steroid-responsive.

• PGN: Good (recovery usually in a few weeks) but wrong in the setting of a restriction to bronchioles (pure BOOP) in patients with BMT (bone marrow transplantation) and H/L-Tx (heart/lung transplantation) and rheumatoid arthritis.

A rare form of acute fibrinous and organizing pneumonia (AFOP) may also occur in childhood. It is characterized by bilateral basilar lung infiltrates on CXR. Histologically, there is organizing pneumonia and intra-alveolar fibrin in the form of "fibrin balls" (Fig. 2.15 ).

UIP is the most common type of chronic interstitial pneumonia in adults, although in at least half of the affected individuals, UIP is idiopathic. UIP is characterized by a spatiotemporal diversity of architectural distortion (old honeycomb fibrosis and active fibroblast foci) and chronic progression to lung failure (4-5 years) requiring H/L-Tx.

• DEF: Idiopathic/specific T H2 -response-driven fibrosis with ↑TGF-β1 (Mϕ activation and innocent bystander tissue destruction) of the lung bilaterally with insidious onset (Fig. 2.16 ). • SYN: Sclerosing/fibrosing alveolitis.

• EPI: Worldwide, ♂ > ♀, >40 years, apart from some children with ABCA3 gene mutations. • EPG: UIP is based on epithelial activation/ injury -iterative processes (the so-called "UIP cycles") by some non-identified agents promoting 1. ⇒ TGF-β-1 (released from injured type I alveolar cells) 2. ⇒ TCF effects, including:

-⇒ ↓ Telomerase (increase of senescence and apoptosis of alveolar cells) -⇒ Caveolin-1 inhibition (fibroblastdirected inhibition) -⇒ Fibroblasts proliferation with myofibroblasts transformation (fibrogenesis) • CLI: Nl. FEV1/FVC or Tiffeneau-Pinelli ratio, including the forces expired volume in the first second and forced vital capacity with the normal value for the FEV1/FVC ratio being 70%, bilateral infiltrates (CXR), and BAL and CT also very useful for PGN. • GRO: Nodular pleural surface with scarring and retraction. • CLM: Patchy interstitial inflammation (lymphocytes, histiocytes [tight intra-alveolar clusters of macrophages], plasma cells, and germinal centers) with foci of heterogeneity ranging from old lesions of cystic changes and honeycomb pattern to active fibroblast foci and narrowed airspaces, subsequent pulmonary hypertensive changes, and smooth mus-cle hyperplasia. • TNT: Steroid response in <20% of cases ⇒ lung and/or H/L-Tx. • PGN: Lung transplantation as ultima ratio.

In pediatric lung biopsies, UIP gross and histology are excessively rare and is likely to remain an exceedingly rare occurrence. However, Young et al. reported UIP in a patient harboring ATPbinding cassette A3 (ABCA3) gene mutations. In a multicenter-based systematic review, no UIP was found over a 5-year period reviewing over 400 children. In our opinion and according to most of the pediatric pathologists, it may be worthy to follow-up more closely patients with ABCA3 gene mutations. ABCA3 protein is located in the limiting membrane of lamellar bodies in alveolar type II cells and both in vitro, and now murine data indicate that ABCA3 functions in the transport of surfactant lipids into lamellar bodies. Thus, it is required to maintain pulmonary surfactant phospholipid homeostasis. Loss of ABCA3 function is responsible for lung disease, and one missense mutation, E292V, was identified in multiple unrelated children who were compound heterozygotes for ABCA3 gene mutations. Respiratory viral infections have been temporally related to the onset of disease in patients harboring SFTPC gene mutations. Clinical genetic testing for mutations in SFTPC and ABCA3 genes may be considered in children and younger adults with lung fibrosis. The progression of UIP is relentless toward idiopathic pulmonary fibrosis (IPF) and is quite worrying, particularly for the more frequent use of tobacco smoking at a younger age. The widespread diffusion of vaping and e-cigarette as well as cannabis may worse irreversibly the lung function of children and youth. The primary challenge in the field of ILDs is the early and accurate diagnosis of this distressing form. IPF has a worse prognosis than that of numerous cancers and has been less tackled by research funding agencies.

The rates of prevalence and incidence of IPF are challenging to estimate because numerous clinical conditions evolved toward this entity in the last decades. Allergic asthma may be an essential and common underlying disorder, but cystic lung dis-ease, scleroderma, radiation, and chemotherapyrelated fibrosis, granulomatous lung disease, sarcoidosis, and environmental causes, as well as smoking-related COPD or the new vaping-related lung disease, are also listed behind the diagnosis of pulmonary fibrosis. The fibrotic stages of these conditions are often fatal because a median survival time has been estimated to be 3-5 years following the diagnosis of pulmonary fibrosis. Although not all pulmonary fibrotic conditions follow the simple paradigm of wound healing, this model may be the underlying pathogenic mechanism for most of these conditions. Immunologically, it is essential to classify the immune response as type 1, type 2, or type 17. Class 1, which is generally considered pro-inflammatory, is characterized by Th 1 cells, IFN-γ, TNF-α, and IgG2 antibody response; class 2 shows Th 2 cells, IL-4, IL-5, IL-13, and IgE and is usually considered a wound healing response; finally, class 17 is characterized by Th 17 cells, which have been associated with pro-inflammatory conditions and based upon the T-helper celldominant cytokine responses.

Despite new progression in the immunological research of the last 20 years, the pathogenesis of pulmonary fibrosis is far to be fully understood. It is well known, one or more insults cause the lung to exhibit fibrosis ("Gewebefibrosierung" or fibrotization), and these insults or singular insult may be occasionally known, although they are unknown most of the time. The insult will lead to alveolar epithelial cell injury and subsequent repair, which may be or, actually, is dysregulated in pulmonary fibrosis very often. There is excessive extracellular matrix (ECM) and loss of typical architecture of the lung parenchyma and, subsequently, loss of lung function. In pulmonary fibrosis, fibroblasts that produce ECM components differentiate into myofibroblasts, which are considered the hallmark cells in the full development and establishment of the full picture of pulmonary fibrosis. Multiple pathways are implicated in the pathogenesis of this disease. Among others, coagulation, apoptosis, and oxidative stress are involved in the pathogenesis of pulmonary fibrosis.

Four distinct stages have been identified in wound healing. There is a clotting/coagulation phase (1), an inflammatory cell-associated migration phase (2), a fibroblast-associated migration/ proliferation/activation phase (3), and a tissue remodeling and resolution phase (restitutio ad integrum) (4). Following a lung injury, there is a release of inflammatory mediators by epithelial cells that initiate an anti-fibrinolytic coagulation cascade, which triggers platelet activation and blood clot formation. After this initial phase, leukocytes (e.g., neutrophils, macrophages, and T cells) enter the sequence, and the recruited leukocytes secrete pro-fibrotic cytokines such as IL-1β, TNF, IL-13, and TGF-β. Activated macrophages and neutrophils then progressively remove dead cells and invading microorganisms. Later, fibrocytes from the bone marrow and orthotopic resident fibroblasts ("autochthonous cells") proliferate and differentiate into myofibroblasts, which release several components of the ECM. Epithelial-mesenchymal transition (EMT) should also be considered to be at the basis of the transformation of epithelial cells into fibroblasts and myofibroblasts. Finally, tissue remodeling and resolution phase take place, and activated myofibroblasts promote wound repair, leading to wound contraction and restoration of vascular nutrition. Fibrosis can develop if a dysregulation can arise at any stage in the tissue repair program or when the lung-damaging stimulus persists. Myofibroblasts, which may be considered dysregulated, originate from a resident pool of tissue fibroblasts in response to tissue injury. Interestingly, these cells organize into small areas of progressive fibrosis, which are called fibroblastic foci. These cells in these areas are the active source of an excessive assembly of ECM proteins.

Pneumonia/Pneumonitis (NSIP)

• DEF: Idiopathic or specific (e.g., collagen vascular disease, drug toxicity, hypersensitivity, post-allogeneic hematopoietic stem cell transplantation) with the temporal homogeneity of cellular interstitial inflammation (e.g., plasma cells) and a variable amount of fibrosis (no or very few fibroblastic foci → inactive, or mostly inactive) (Fig. 2 1. Cellular (interstitial chronic inflammation with lymphocytes and plasma cell and preservation of the lung architecture) 2. Fibrosing (patchy/diffuse, but temporally uniform interstitial fibrosis)

Patients with NSIP, fibrosing pattern are older than patients with NSIP, cellular model.

• HCT: Mostly ground-glass opacities, bilateral, basal and peripheral as well as reticular, linear patterns in 1/2 of patients. • CLM: Lung architecture-preserving spatiotemporal uniformity with mild-moderate inflammation ± lymphoid follicles, type II pneumocyte hyperplasia, and scant to dense interstitial fibrosis and "traction" bronchiolitis. No granulomas, no MNGC, no bronchiolocentric distribution, no acute lung injury pattern, no hyaline membranes, no prominent eosinophils, and no evidence of infection. NSIP mnemonic word is ULF ("uniform lymphoid follicles"). • DDX: UIP (spatiotemporal heterogeneity with fibroblastic foci, collagenous deposition, and honeycomb changes). It is mandatory to rule out the following diagnoses in every case: collagen vascular diseases, drug reaction, chronic hypersensitivity pneumonitis, immunodeficiency-related changes, infection, and slowly resolving acute interstitial pneumonia. • TRT: Steroid-responsive.

• PGN: 5-YSR: 80-90%.

• DEF: DILD, often associated with cigarette smoking (potentially also vaping), relatively good steroid-responsive, but occasionally relentless with significant mortality, and characterized by a uniform (spatially and temporally) intra-alveolar involvement of the lung more than interstitial inflammation ( Fig. 2.18 

• DEF: ILD with similarities to DIP, but harboring the tendency to patchiness, limit to the involvement of respiratory bronchioles (bronchiolocentric) ± alveolar ducts, and tendency to distend lumina (bronchiolar and peribronchiolar MΦ accumulation with standard large areas of intervening lung parenchyma) ( Fig. 2.19 ). • EPI: Early smokers, 30-60 years, depending on the amount and length of smoking and living conditions (urban vs. rural). The role of vaping is under intense investigation, and this phenomenon seems to be quite diffuse in teenagers. In several countries the regulation of the sell and use of these products may take place at late stages because the current use of vaping among children and teenagers or children and adolescents exposed to vaping in social events has fearfully increased in the last couple of years with rates ranging from 40% to 60%. pneumonia, granulomas, MNGC, a foreign material other than pigment of anthracosis, numerous eosinophils, and neutrophils. • TRT: Passive/active smoking cessation, because passive cigarette smoke exposure may prevent improvement or lead to recurrence of the disease. Some patients benefit from corticosteroids. • PGN: The natural clinical course of the disease is unknown, but the prognosis is good with the avoidance of passive or active smoking exposure.

• DEF: ILD with multinodular infiltrates of Langerhans cells with the centrilobular involvement of respiratory bronchioles (peribronchiolar) and with large common areas of intervening lung parenchyma ( Fig. 2.20) . In adults, it is smoking-associated with "smokers' macrophages" (Prussian blue +), while in children and adolescents, it is infrequently associated with passive smoke exposure. The pediatric form may be characterized by multifocal involvement (10-15%) with mainly bone and systemic disease. • SYN: Langerhans cell granulomatosis, histiocytosis X. • EPI: Adult PLCH (smokers, 30-60 years, depending on the amount and length of smoking, and living conditions) and pediatric PLCH (rare, insufficient data).

• CLI: Dyspnea, ± fever, and pneumothorax (PNX), which represents air-collection between parietal and visceral pleura with consequent collapsed lung developing as a complication of the trapped air. • IMG: Centrilobular/peribronchiolar reticulonodular infiltrates, diffusely scattered, mainly upper and mid-lung fields. • GRO: Smoking-associated changes related to COPD (chronic bronchitis and emphysema). • CLM: Patchy, nodular interstitial lesion with centrilobular distribution with stellate architectural involvement/scarring due to extension along alveolar septa with numerous histiocytes with variable numbers of eosinophils, plasma cells, lymphocytes, and MΦ and often nodular cavitation leading to cyst formation. • IHC: (+) S100, CD1a, Langerin.

• TEM: Birbeck granules ("tennis-racket" cytoplasmic organelles of Langerhans cells; Birbeck et al. 1961 

• DEF: ILD with a mixed cellular interstitial infiltrate of lymphocytes, plasma cells, epithelioid histiocytes, germinal centers, and granulomas with a variable degree of symptomatology and imaging features ( Fig. 2.21 disorders may also be suggested as LIPassociated disorders of the lung tissue. In fact, LIP has also been considered an early lymphoproliferative lesion of pulmonary MALT (mucosa-associated lymphatic tissue). • EPI: Any age.

• EPG: Autoimmunity (e.g., Sjögren's syndrome), viruses (e.g., HIV), dysproteinemia have been associated to LIP. • CLI: Gradual onset of dyspnea, cough (>6 months) ± immune-related disease (e.g., collagen vascular diseases, multicentric Castleman disease, immunodeficiency, e.g., AIDS, SCID) ± polyclonal γ-GB-changes (↑/↓-γ-GB-emia). • CTI: Ground-glass opacities, perivascular cysts ± perivascular honeycombing (late stage). • CLM: Spectrum of peribronchiolar/peribronchial polyclonal lymphoplasma cellular proliferations that include follicular bronchitis/ bronchiolitis (BALT hyperplasia) with scattered reactive lymphoid follicles (Ø ≥ 1 mm) around bronchioles and bronchi, nodular lymphoid hyperplasia, and, in case of monoclonality, low-grade B-cell lymphoma (MALT-oma). The lymphoid follicles can compress bronchiolar lumina, and distal changes of obstructive pneumonia can be observed, and a mild infiltrate can also be seen into adjacent alveolar septs and when a congruous interstitial infiltrate is present there may be an overlap between follicular bronchiolitis and LIP. In follicular bronchiolitis as well as LIP, there is a mixed polytypic infiltrate of B and T cells, although T lymphocytes predominate in LIP, while B lymphocytes dominate in follicular bronchiolitis (FOB). • DDX: It includes follicular bronchiolitis, ENMZ-BCL, nodular lymphoid hyperplasia, and hypersensitivity pneumonitis. Moreover, the marked interstitial lymphoplasmacytic infiltration, which expands the alveolar septa, also needs to be carefully distinguished from cellular NSIP, i.e., the fibrosing subtype of NSIP with collagenous fibrosis, which is diffuse but lacking structural remodeling. • PGN: Variable depending on the stage.

• TRT: Steroid-responsive with regard to the follicular bronchiolitis/bronchitis.

An entity that seems to be controversially discussed in books and papers is lymphomatoid granulomatosis (LYG). Although not necessarily associated with LIP, it may be necessary to address LYG here for the predominance of lymphocytic infiltrates seen in both conditions. Angiocentric and angio-destructive pathologic disease process that more often affects the lung as bilateral nodular infiltrates constituted of a mixed population of lymphoreticular cells lacking specific granulomatous features.

LYG affects both sexes (♂ > ♀), the fifth decade of life with lung>CNS>skin>liver>kidney, but adolescents and youth may also been affected. It is debated how much is the lymphoproliferative process active in LYG. However, the current WHO criteria indicate that LYG is a distinct form of T-cell-rich large B-cell lymphoma. Diagnostic criteria include (1) mixed mononuclear cell infiltrate composed of an angiocentric and angio-destructive formation of large and small lymphoid cells with often plasma cells and histiocytes and the fate to replace the lung parenchyma implementing a clearcut vascular infiltration and (2) variable cell population of T-cell-rich B-cell infiltration, which are CD20-(+) large B cells in a background of CD-3-(+) small lymphocytes. There are optional findings, although supportive, not often seen. They include necrosis of the cellular infiltrate with positivity for EBER (in situ hybridization for Epstein Barr virus or EBV RNA), multiple lung nodularity, skin involvement and CNS involvement. The WHO recommendation is that LYG is graded as 1, 2, or 3, according to the number of EBV-positive large B cells, being grade 1 containing <5 EBV+/HPF, grade 3 > 50 EBV+/HPF, while grade 2 between 5 and 50 EBV (+)/HPF. Treatment of LYG includes IFN α-2b for both classes 1 and 2, while DLBCL therapy is indicated for class 3 LYG.

• DEF: ILD with a specific immunologic reaction to inhaled agents (e.g., fungus, mold, ani-mal proteins), often labeled according to the job of affected people (e.g., farmer's lung, maple bark stripper's disease, pigeon breeder's disease), or to the etiologic agent (e.g., byssinosis, actinomycosis). • SYN: Extrinsic allergic alveolitis.

• EPG: Combination of type III (immune complex)-associated hypersensitivity responsible for the acute inflammation features and type IV (cell-mediated)-driven hypersensitivity reactions accountable for the formation of granulomas. • CLI: Essentially, two forms.

• Acute (substantial exposure): Severe dyspnea, cough, fever about 6 h after exposure and usually resolving in 12-18 h (self-limited), although continued exposure can lead to permanent damage (chronic ⇒ DILD -chronic hypersensitivity pneumonia/itis). • Chronic: Prolonged exposure to small doses and insidious onset of dyspnea and dry cough (restrictive lung disease) and characterized by "BIG": 1. Bronchiolo-centric Interstitial pneumonia/ pneumonitis 2. (patchy, peribronchiolar, temporally synchronized, with uninvolved lung parenchyma in between, with CD4 < CD8 T-lymphocytes, plasma cells, histiocytes, and rare eosinophils/neutrophils) 3. Non-necrotizing epithelioid Granulomas with giant cells, ± 4. BOOP-like changes (2/3 cases) • TRT: Steroids.

• PGN: Steroid-responsive, elimination of the etiologic agent, restrictive lung disease.

Mnemonic word: BIG (Bronchiolo-centric Interstitial pneumonia/pneumonitis and nonnecrotizing epithelioid Granulomas with giant cells).

Actinomycosis, which may have some different clinical forms (cervicofacial, thorax, and abdomen), may enter in the differential diagnosis. Actinomycosis is a subacute/chronic bacterial infection triggered by filamentous, Gram (+), non-acid-fast anaerobic to microaerophilic bacteria. It has a contiguous spread ± "sulfur discharge" and suppurative and granulomatous inflammation ± multiple abscesses and fistulas. The clinical forms of actinomycosis include the cervicofacial, thorax, and abdomen (pelvic actinomycosis).

Eosinophilic pneumonia is a sophisticated group of diseases accommodated in a heterogeneous collection characterized by the accumulation of eosinophils in the lung parenchyma with or without peripheral blood eosinophilia. Eosinophilic pneumonias are usually divided according to their etiology (idiopathic or secondary), clinical presentation, or morphology.

• DEF: Eosinophilic pneumonia characterized by acute onset (<7 days), the presence of fever, severe hypoxemia, radiological pulmonary infiltrates ± PB eosinophilia ( Fig. 2.22 ). • EPI: Unknown incidence, all ages, ♂ = ♀.

• EPG: New-onset smokers, fireworks smoke, heroin and crack cocaine smoking. A sentinel case was reported in a young firefighter after inhaling World Trade Center dust following the September 11, 2001 terroristic attack (Rom et al. 2002) . The etiology in childhood and adolescence is somewhat heterogeneous. • CLI: Rapid onset (<7 days) with fever, dyspnea, hypoxemia, BAL >25% Eos, ↑ SP-A and SP-D and patchy bilateral, mostly peripheral pulmonary infiltrates. Other symptoms may include myalgias and pleuritic chest pain. On auscultation, patients show bibasilar crepitation without wheezing (Box 2.9). • IMG: Thickening of bronchovascular bundles (random distributed) and pleural effusions. • GRO: DAD-like appearance but depends on the extension of the DAD. • CLM: Alveoli filled with eosinophils and large MΦ or giant cells, DAD, necrotic debris, and palisading histiocytes with accompanying interstitial infiltrate of eosinophils and other inflammatory cells, mild non-necrotizing vasculitis, and ± bronchiolitis obliterans. • DDX: The laboratory workup should include a complete blood count with differential, bronchoalveolar lavage, analysis of stool for ova and parasites, serum immunoglobulin levels, ESR, and cultures for bacteria and fungi.

• TRT: Steroids and respiratory support. • PGN: Variable, but usually good if there is a prompt response to corticosteroids.

If AEP is compared to CEP, there are a few aspects that need to be considered. The severity of damage to the basal lamina and the amount of following intraluminal fibrosis in CEP is more than AEP. In fact, in AEP, intraluminal fibrosis is virtually absent. Some drugs have been associated with AEP, including acetaminophen, bleomycin, carbamazepine, chlorpropamide, cromolyn sodium, dapsone, daptomycin, glafenine, imipramine, Maloprim, minocycline, naproxen, oxymetazoline, procarbazine, sulfanilamidecontaining vaginal cream, sulfasalazine, trazodone, and tetracycline. An accurate medical and pharmacological history is paramount for both pediatric and adult cases. In Churg-Strauss syndrome, tissue eosinophilia is accompanied by Notes: The mnemonic word CAST serves to memorize the five types, keeping in mind that the letter S is used twice; PB peripheral blood vasculitis (PAN-like) and necrobiotic palisaded granulomas. The list of diagnoses of the thickening of the bronchovascular bundles on chest CT imaging other than the pulmonary interstitial edema includes acute eosinophilic pneumonia, lymphangitis carcinomatosis, lymphoid interstitial pneumonia, microscopic polyangiitis, mycoplasma pneumonia, and sarcoidosis.

Progressive massive fibrosis (PMF) is an extreme complication of silicosis, asbestosis, and coal worker's pneumoconiosis with virtually sparing of children and youth. PMF needs to be explained to youth affected with UIP and the relapse and persistence of some environmental issues. Clinically, dyspnea, even at rest, associated with localized chest pain is common, and right ventricular hypertrophic heart may be the reason for H-L/TX in some affected individuals. Microscopically, there are large amorphous masses of fibrous tissue. There is a tendency to obliterate and contract the lung parenchyma. It occurs preferentially in the upper lobes, where silicosis is frequent. Two life-threatening complications are cavitation, due to necrobiosis or TB and Caplan syndrome, which is characterized by multiple firm tan nodules with central necrosis (aka rheumatoid nodules) in the setting of PMF (Chiavegatto et al. 2010 ).

Inflammation of the tracheobronchial system is persistent in pediatric and young adult population. Primary concerns are the increased level of air pollution in several countries and the habit to tobacco smoking and vaping, which seems to be increased in a very young population, at least in some countries. Although it should be illegal selling cigarettes or other tobacco products to individuals younger than 18 years old, the reality is that 6.2% Canadians (~1/20) aged 15-24 indicated using e-cigarettes in the past month, while 23.9% (~1/4) indicated having ever tried e-cigarettes (Mehra et al. 2019) . (Box 2.10).

Laryngotracheitis may herald a lung disease and may be associated to several drugs that may be ingested or substances that can be inhaled. There are a few, but essential, drugs that are important to remember and that can cause lung disease in children and youth. The pathology of laryngotracheitis mirrors the adult pathology ( Fig. 2.23) . A textbook of clinical pharmacology and/or respiratory medicine are essential to complement the information of this chapter.

Inflammation of the bronchial system with critical neutrophils in both lumen and invading the surface epithelium. This pathology mirrors that of adulthood.

• DEF: Increased responsiveness of the tracheobronchial tree to various stimuli (extrinsic or intrinsic), leading to paroxysmal airway constriction, which is potentially life-threatening ( Fig. 2.24 ). Interview Survey of the USA, and the lifetime prevalence of asthma in children remains about 10%. • EPG: Three types -extrinsic (atopic, allergic), most common, and intrinsic (idiosyncratic); now recognized a mixed form. In the extrinsic type, there is the initial sensitization affecting the T H2 , which release IL4/5, which promote IgE release by B cells, mast cells, and eosinophils. The re-exposure to allergen leads to mediator release from mast cells that reside in the bronchial mucosa. • CLI: Unremitting attacks (status asthmaticus)

can be fatal (pulmonary hyperinflation). • IMG: Typically, CXR is not significant, because history and physical exam are the cornerstones for the diagnosis; CXR can disclose some complications, including pneumomediastinum, pneumonia, or a foreign body in the airway. • GRO: Overdistension of the lungs with areas of atelectasis and mucus plugs in proximal bronchi. The condition may reach a full overdistension of both lungs, which is also called "Volumen pulmonum auctum" corresponding to the German word "Lungenüberblähung" or, literally, enlarged volume of the lungs. • CLM: Bronchial lumen plugging by thick mucus plugs containing eosinophils, whorls of shed epithelium (Curschmann spirals), and Charcot-Leyden crystals (eosinophilic membrane protein) and directly communicating distal airspaces over distended with thickening of the subepithelial basement membrane, edema, and inflammation in bronchial walls with prominence of eosinophils and hypertrophy of bronchial wall muscle (Box 2.11). • DDX: Foreign body aspiration is the first differential diagnosis that needs to be ruled out in an emergency department. • TRT: Therapeutic agents are aimed at increasing cAMP levels either by increasing production (β2-agonists, e.g., epinephrine) or decreasing degradation (methylxanthines, e.g., theophylline). Cromolyn sodium prevents mast cell degranulation • PGN: It may be potentially fatal. There may be a tracheobronchial disease with a series of possible complications, including ABPA, right heart-related congestive heart syndrome (cor pulmonale chronicum), acute hyperinflation without expiration possibilities, and volumen pulmonum auctum as indicated above (auctus derives from the Latin and means enlarged).

• DEF: Atelectasis in the right middle lobe of the lung caused by various etiologies without a consistent clinical definition. • EPI: The precise incidence in children is unknown. RMLS is widely underdiagnosed and frequently unrecognized. RMLS is more often to see in girls than in boys and particularly in children with a history of asthma or atopy. • EPG: Although the mechanism by which asthma leads to lobar atelectasis is unknown, inflammation, bronchospasm, and secretions that cause mucus plugging are likely significant contributors. Specific anatomical features make the RML susceptible to transient obstruction as a result of frank inflammation Notes: ~ variable; #, number; Curschmann's spirals are microscopic spiral-shaped mucus plugs found in the sputum and arising from subepithelial mucous gland ducts of bronchi. Of note is that in patients with quiescent asthma or history of asthma, the airways may appear entirely normal or otherwise show minimal changes of inflammatory or fibrotic type (Fig. 2.24) or edema. The slender Ø of the lobar bronchus and the acute takeoff angle create poor conditions for drainage. Bronchial obstruction can result from extrinsic compression as in hilar lymphadenopathy or tumor of neoplastic origin; however, atelectasis in children usually occurs from a process such as bronchial asthma-associated edema and inflammation. Foreign body aspiration into the RML orifice can also predispose to collapse of the lobe.

• GRO: Wedge-shaped density that extends anteriorly and inferiorly from the hilum of the lung. • CLM: Histologically, chronic bronchitis/bronchiolitis with lymphoid hyperplasia, patchy organizing pneumonia, atelectasis, granulomatous inflammation, and an abscess can be seen. In patients with granulomatous inflammation, an associated atypical mycobacterial infection can also be observed (Fig. 2.25 ). • TRT: Cause-specific management. Many RMLS patients respond to medical therapy alone.

• PGN: The chance of reinflation once atelectasis occurs is due to both the relative anatomical isolation of the RML and poor collateral ventilation decrease. Severity in children ranges from mild atelectasis and scarring of no consequence to severe bronchiectasis requiring surgical resection.

• DEF: Life-threatening acute/hyperacute increased air content of the lung. • SYN: Volumen pulmonum auctum (vide supra).

• EPI: Case fatality from asthma in the USA is estimated at 5.2 per 10 5 , with wide variations across Europe (e.g., 1.6 per 100,000 in Finland and 9.3 per 100,000 in Denmark). • ETP: In obstructive airways, the expiratory airflow is more affected than the inspiratory airflow; at the end of an exhalation, there is ↑air in the lung (acute pulmonary obstruction).

Although the ↑ of the intrathoracic gas volume is first reversible, chronic pulmonary hyperinflation results in irreversible pulmonary emphysema as a result of structural changes (e.g., asthma in teenagers and COPD in adults). In summary, two forms have been delineated, including an absolute hyperinflation or static (anatomically fixed pulmonary hyperinflation) with ↑ in total lung capacity (TLC) and, a probably enigmatic relative hyperinflation or dynamic with air trapping and ↑ residual volume (RV) at the expenses of the vital function. The use of e-cigarettes, vaporizers, and inhalers is being intensely investigated worldwide, but it seems that the damage from these forms of recreational activity may increase the rate of respiratory insufficiency of young adults in the nearest future. • CLI: Life-threatening emergency with shortness of breath. • CXR: Hypertransparency of the lungs (diminished density of the lung tissue), diaphragm level with flattened diaphragm couplings, drop heart -heart drawn with the heart downward, with the heart tip pointing downward as a result of the diaphragmatic lobe, and "Barrel chest" ("Fassthorax" of the German literature), broadened sagittal diameter with horizontally arranged ribs and extended intercostal spaces. • GRO: Hyperinflation of both lungs with apical bullae. • CLM: Acute marked distension of the alveolar spaces. • DDX: It includes mostly a foreign body aspiration with occlusion of the bronchial airways. • TRT: Some protocols are available for acute exacerbation of bronchial asthma and are available in internal medicine and pediatric respiratory books. • PGN: Life-threatening condition with immediate medical intervention.

• DEF: Permanent abnormal dilation of bronchi and bronchioles, usually associated with mucus plugging of the draining bronchial system and chronic, necrotizing inflammation. • EPI: It may be quite variable, and CF, CVID, and ABPA may influence the correct rates. • CLI: Fever, cough, and foul-smelling sputum.

• GRO: More often seen in left lung and more common in lower lobes. • CLM: Bronchial lumen dilation + mucus plugs + chronic necrotizing inflammation. • DDX: It includes some conditions including alpha-1-antitrypsin deficiency, congenital cartilage deficiency, RMLS, primary cilia dyskinesia (immotile cilia, Kartagener syndrome), pulmonary sequestration, tracheobronchomegaly, and "unilateral hyperlucent lung" (Swyer-James syndrome). Middle lobe syndrome is recurrent/permanent atelectasis of the right middle lobe or lingual with chronic inflammation associated with lymphadenopathy and/or malignancy (Gudbjartsson and Gudmundsson, 2012 

There are very few literature data on tracheal neoplasms in childhood. The most frequent diagnoses of tracheal neoplasms include the chondroid hamartoma, tracheal chondroma, inflammatory myofibroblastic tumor, mucoepidermoid carcinoma, and rare occurrences of primary small round blue cell tumor (e.g., Wilms' tumor or rhabdomyosarcoma) (Fig. 2.23) . Some of these entities will be discussed in detail later in the neoplasms of the lower bronchial system in this chapter.

Infections of the bronchial and lung system are usually different among children, adolescents, young adults, older adults, and immunocompromised patients. Bacterial pneumonia is generally seen in adults, while viral or mycoplasma pneumonia is seen in children and youth. Opportunistic organisms (e.g., Candida, Histoplasma, Pneumocystis jiroveci) are at the origin of pneumonia in patients with altered host defense mechanisms such as prolonged antibiotic therapy, cancer chemotherapy, immunosuppressant drugs, and immunodeficiencies. Bacteria tend to cause pneumonia, which shows an intra-alveolar exudate leading to tissue consolidation, while viruses, Chlamydia spp., and mycoplasmas are prone to induce pneumonitis with a mainly interstitial infiltrate. Pneumonia may also be subdivided in segmental or lobular if the inflammatory process is patchy involving only a segment of a lobe and lobar if an entire lobe is involved. 

• DEF: Multifactorial syndrome at neonatal onset with lower respiratory tract involvement due to absolute or relative, mostly diffuse, inflammatory alteration of the lung parenchyma. In more than 90% of cases, the agent is Streptococcus pneumoniae, most commonly types 1,3,7, and 2. Other agents are Klebsiella pneumoniae, Staphylococcus aureus, and Haemophilus influenzae.

Classically, four stages are seen, including:

• is a Gram-positive, α-or β-hemolytic, facultative anaerobic member of the genus Streptococcus and characteristically the etiologic agent in alcoholic, debilitated, or malnourished individuals. During the four stages, there is initially an exudate of RBCs, PMNs, and fibrin that is progressively removed by the intra-alveolar entry of MΦ and lymphocytes, which characterize the late stages of lobar pneumonia with eventual resolution. It is important to remember that bacterial lobar pneumonia may complicate lung parenchyma following trauma, hemorrhage, infarction, neoplastic infiltration, and pneumonitis due to aspiration of gastric contents or inhalation of chemicals or toxins. 

Multifactorial syndrome with lower respiratory tract involvement due to primary infection from Staphylococcus, Pseudomonas, Proteus, Klebsiella, and other Gram-negative coliform bacteria, which may often be considered hospital- 

It is usually virally based pneumonia with CMV, RSV, and measles virus as well as ortho-and paramyxoviruses as critical etiologic factors, particularly in immunocompromised patients. Viruses have a cytopathic effect directly against the epithelial cells of the lower respiratory tract with subsequent cell necrosis, necrotizing bronchitis, and terminal bronchiolitis, particularly adenovirus. Microscopically, there is atelectasis of the central lobule, prominent and edematous septs, and an inflammation consisting of lymphocytes, plasma cells, and histiocytes involving the interstitium. Hyaline membranes may also be seen in severe cases due to diffuse alveolar damage.

It is infectious pneumonia, which is often seen in children and young adults and due mainly to M. pneumoniae, Legionella pneumophila, and Chlamydia trachomatis. The term atypical refers to the absence of the typical exudates and consolidation of lobar pneumonia. Microscopically, there are interstitial inflammation with bronchiolitis, erosion of the bronchial epithelium, and peribronchial lymphoplasmacytic infiltrates. A rising titer of cold agglutinins is seen in primary atypical pneumonia.

Non-infectious forms of lung inflammation or non-infectious pneumonia include aspiration and chemical pneumonitis, lipoid pneumonia/pneumonitis, hemorrhagic pneumonitis, eosinophilic pneumonia, and hypersensitivity pneumonitis (Box 2.13).

Aspiration and chemical pneumonitis are defined as the passage of material from the oropharynx Fig. 2.29) . The predisposing conditions leading to tracheobronchial aspiration include neurological disease; esophageal diverticula, such as Zenker's diverticulum, gastroesophageal reflux, and swallowing disorders; intoxication/drug overdose/anesthesia (recent); and seizures (including febrile fits associated with a significant ↑ in body °C). Symptoms depend on the type of material aspirated, the volume aspirated, and state of consciousness of the subject. The fate of aspiration depends on what is aspirated into the lungs. Thus, un-neutralized gastric acid produces a chemical pneumonitis, aka Mendelson syndrome. This syndrome can produce almost instantaneously airspace disease. If the volume of the aspiration is massive, the pattern is that of pulmonary edema. Mortality is up to 60% of the cases. Conversely, water or neutralized gastric acid may produce an ephemeral disease that can resolve in hours if aspiration does occur. Aspiration of bacteria can produce pneumonia. Community-acquired infec-tions tend to be caused by Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Enterobacteriaceae, while hospital-acquired infections tend to be etiologically associated with Pseudomonas and other Gram-negative organisms. Typically, aspiration occurs in the gravity-dependent portions of the lung, such as the superior segments of the rightsided lower lobes (on the right, because of the larger caliber and straighter course of the right main bronchus) and the posterior parts of the upper portions. In a prone patient, aspiration is mostly in the right upper lobe and middle lobe or the lingual. Chronic aspiration pneumonia/ pneumonitis is most frequently seen in patients with esophageal diverticula, achalasia, TEF, neuromuscular diseases, and GERD. Lipoid material causing lipoid pneumonia/pneumonitis may be mineral oil (used as a laxative) or oily nose drops. Clinically, there are choking or swallowing, acute respiratory distress, productive cough, and low-grade fever. Conventional CXR shows a a b c d fleeting infiltrate if bland and non-infected, while lobar consolidation is seen with the aspiration of anaerobic organisms or un-neutralized HCl. Grossly, the lung is firm and the lung parenchyma appears flesh-like. An important task requested to the pathologist, particularly to pediatric pathologist receiving a bronchoalveolar lavage (BAL) from a patient with a history of aspiration or suspicion of aspiration pneumonitis, is to perform the semiquantitative evaluation of the Oil Red O (ORO)-stained macrophages. ORO special stain needs some precautions, including avoiding alcohol-containing fixatives (propylene glycol is used instead) and frozen section (10 microns in thickness) or cytospin air-dried for at least 15 min. The adrenal gland or fatty liver should be used as control tissue. Neutral lipid stains in red, whereas nuclei are counterstained in blue using Mayer's hematoxylin. Differential cell counting is helpful to identify how many macrophages are present, but ORO stain is a useful tool for the quantification of lipid-laden macrophages, a finding identified as early as 1928. Continued aspiration leads to the accumulation of lipid-laden macrophages in the alveolar spaces. Repeated aspiration of gastric contents may be the consequence of recurrent pneumonia, asthma, bronchitis, and atelectasis. It has been proposed that the mere presence of lipid-laden macrophages in the lower respiratory tract is a marker of pulmonary disease related to aspiration. However, intra-and interobserver variability is a significant problem in evaluating this parameter in the BAL. In 1985, Corwin and Irwin found an increased number of lipid-laden macrophages in the BAL specimens of chronic aspirators and used these cells to create a semiquantitative test of aspiration called the lipid-laden macrophage index (LLMI). Subsequently, Colombo and Hallberg modified the LLMI using extensive studies in rabbits, and the test is now commonly used to evaluate aspiration in children. Langston and Pappin use descriptive terms in their reports such as none, rare, moderate, or numerous lipid-laden macrophages rather than the numerical values. Collins et al. have proved to use a 4-grade system to score the number of lipid-laden macrophages in a semiquantitative way (grade 0, none; 1, 1-25; 2, 26-50; 3, >50 lipid-laden macrophages per slide). Yang et al. have suggested counting 100 macrophages but to use a 2-grade system (grade 1, if macrophages have less than 50% cytoplasmic lipid and grade 2 if macrophages show more than 50% lipid). However, several studies have raised some limitations for this score or any other scoring systems, and it is not considered a gold standard yet, although in many institutions is used. LLMI limitations come out when healthy non-aspirating children and adults have elevated LLMIs. Possible causes are parenteral nutrition with intravascular intralipid in infants, subclinical aspiration in otherwise healthy children, and tissue breakdown of surfactant. LLMI may also be elevated in ILD, lung neoplasms, obesity, COPD, and smoking. Any quantitative measurement tool is subject to inter-and intraobserver variability, but the degree of variability should be minimal if test results are to be considered reliable and reproducible. A k-value of ≥0.75 has been suggested as an optimal cutoff. The lack of such characteristics allows questioning the utility and validity of such test. Clinicians and (cyto-)/pathologists comparably should be aware of this pitfall and interpret LLMI accordingly.

• DEF: An explicit form of pneumonia that develops when lipids enter the bronchial tree. • SYN: "Golden pneumonia." • EPG: (1) Endogenous lipoid pneumonia due to the tumor, LN, abscess ⇒ lipid-derived from degenerating type II pneumocytes, cholesterol clefts, and MNGC. It is paramount to remember that exogenous lipoid pneumonia due to aspiration of lipid material more often occurs into the right lung than left and this phenomenon takes place because of the non symmetrical bronchial airways anatomy. • GRO: Well circumscribed, firm lung or part of it.

• CLM: Lipid accumulation within foamy MΦ accompanied by inflammation, proliferating type II pneumocytes, cholesterol clefts, MNGC ± reactive endarteritis.

Diffuse pulmonary hemorrhagic syndromes is a heterogeneous group of syndromes with diffuse lung involvement and characterized by intrapulmonary bleedings (Box 2.14).

• DEF: Autoimmune pulmonic-renal disease characterized by circulating autoantibodies against the non-collagenous 1 (NC1) domain of an α3 chain of collagen IV • SYN: Anti-basement membrane (BM) disease. • EPI: Worldwide, ♂:♀ = 2:1, children/youth. • EPG: HS-II with the initial inflammatorybased destruction of both the BM of pulmonary alveoli giving rise to a necrotizing hemorrhagic interstitial pneumonitis and the BM of renal glomeruli with a secondary proliferative and rapidly progressive glomerulonephritis (HS-II, hypersensitivity type II). • CLI: (1) Lung symptomatology with hemoptysis, pulmonary infiltrates (CXR), and anemia-related respiratory symptoms and (2) kidney symptomatology with the acute nephritic syndrome (vide infra). • LAB: (+) Serum for an anti-NC1 α3 chain of collagen IV antibodies, anemia, ↑ of nephritic syndrome-related serology markers. • GRO: Heavy lungs ("pulmōnēs gravēs") with focal areas of necrosis. • CLM: (1) Necrotizing hemorrhagic interstitial pneumonitis with RBCs accumulation and hemosiderin deposition in the alveoli, ↑ alveolar Mϕ and pneumocytes type II, and nonspecific thickening of the alveoli but no vasculitis (usually) and (2) 

• DEF: Probably autoimmune pulmonicrestricted disease characterized by diffuse alveolar hemorrhages without the renal involvement and no identifiable circulating autoantibodies. • EPI: Worldwide, ♂ = ♀, children and youth.

• EPG: Although it is not fully understood, IPH is probably an autoimmune disorder with initial damage to the lung capillaries of the alveoli and subsequent bleeding with iron accumulation and progressive pulmonary fibrosis. • CLI: Lung symptomatology with hemoptysis, pulmonary infiltrates (CXR), and anemiarelated pulmonary symptoms. • LAB: Serology (−) for an anti-NC1 α3 chain of collagen IV antibodies, in addition to anemia and lack of nephritic syndrome-related serology, as seen in Goodpasture syndrome. • GRO: Brown heavy lung parenchyma.

• CLM: Necrotizing hemorrhagic interstitial pneumonitis with RBCs accumulation and hemosiderin deposition in the alveoli, ↑ alveolar Mϕ and pneumocytes type II, and nonspecific thickening of the alveoli but no vasculitis (usually). • PGN: Often self-limiting, improving without therapy, but may be fatal in some cases. Notes: Necrotizing capillaritis is substantially the basis that is present in microscopic polyangiitis (MPA), Wegener granulomatosis (WG), systemic lupus erythematosus (SLE), but also Churg-Strauss syndrome/eosinophilic granulomatosis with polyangiitis (CSS/EGPA), although it is less commonly seen in this entity.

Necrotizing capillaritis is the basis that is present in microscopic polyangiitis (MPA), Wegener granulomatosis (WG), systemic lupus erythematodes (SLE), but also Churg-Strauss syndrome, although it is less common in this entity.

MPA is a necrotizing capillaritis, while WG is a T-cell-mediated hypersensitivity reaction, probably to inhaled infective agents or some environmental agents with subsequent development of a necrotizing capillaritis and granulomas of the upper and lower respiratory tract as well as focal or diffuse necrotizing glomerulonephritis with the crescent formation of the top urinary system.

Granulomatosis with polyangiitis, idiopathic pulmonary hemosiderosis, and Goodpasture syndrome may be the major players of the pulmonary hemorrhagic syndromes.

• DEF: Disorder that causes inflammation of the blood vessels in the nose, sinuses, throat, lungs, and kidneys. • SYN: Wegener granulomatosis.

• CLI: Upper and lower respiratory tract (URT and LRT) mucosal ulceration + c-ANCA (+) (70%). • CLM: Extravascular necrotizing granulomas (URT and LRT) + generalized vasculitis + GN (necrotizing FSGN/crescentic, pauciimmune): serpiginous/geographic necrosis with nuclear debris ("dirty" necrosis) surrounded by loose/palisaded granulomatous inflammatory ± MNGC. • Variants:

Eosinophilic, bronchocentric, BOOP-like.

• DDX: Lymphomatoid granulomatosis (atypical lymphocytes), TB (caseating granulomas, ZN (+), ARC (+)), sarcoidosis with necrotizing angiitis (confluent granulomas), ABPA (GMS (+)). • PGN: Better prognosis is the limited form of the lung when compared to the multivisceral involvement, but the lung can also heal with moderate/severe fibrosis ⇒ UIP.

In this category, there are varieties of gross and microscopic patterns, and it is essential to keep in mind that an infectious granulomatous inflammation can mimic any of the non-infectious granulomatous diseases (Box 2.15). Thermally dimorphic fungi have hyphae that produce spores at environmental temperatures and grow as yeasts (spherules/ellipses) at body temperature (intrapulmonary). Characteristically, in Ohio and Mississippi rivers as well as the Caribbean, the Histoplasma is ubiquitous. In Central and Southeastern USA, there is more often Blastomyces as fungus, while the Coccidioides is prevalent in Southwest and Far West of the USA and Mexico.

• DEF: Chronic granulomatous inflammation of the lung and other organs (multivisceral forms) caused by the infection with Mycobacterium tuberculosis (Fig. 2.30 ). • SYN: Koch bacillus infection.

• EPI: The epidemiology of tuberculosis (TB) in high-income countries is increasingly linked with immigration, and the influence of this trend on pediatric TB is far to be correctly defined. Foreign-born children or North America-born children of foreign-born parents account for an increasingly large proportion of total cases currently. and kidney, h). Miliary tuberculosis is named as such because of the innumerable tiny spots that form in the lungs are the size of millet, which is the small round seed in bird food (mean, 2 mm; range, 1-5 mm)

• EPG: M. tuberculosis. Other mycobacteria may present with similar findings. Initially, M. tuberculosis was on the spot because a transmission by inhalation and targeting humans was determined, but M. bovis has more recently been found to cause GI infections from infected milk and be an important cause of tuberculosis dissemination. In fact, according to recent epidemiological and microbiological investigations, M. bovis has been found as the cause of pulmonary tuberculosis as well. • CLI: Signs and symptoms of active TB include >3 weeks lasting coughing, bloody expectorate, chest pain, or pain with breathing or coughing, failure to thrive, weight loss, fatigue, fever, night sweats, and chills. • GRO: Consolidation of the focus at the pulmonary areas where there is the most significant volume of air flow. • CLM: Slightly wavy or beaded bacteria, which are Gram+, ZN+, SS+, and AFB+ and located in the caseating granuloma, which is the hallmark lesion of tuberculosis ("soft tubercle"). The "hard tubercle" represents granulomas with a cellular center. Ghon focus: 1-1.5 cm gray-white inflammatory nodule seen at the periphery of the upper part of a lower lobe or lower part of upper lobe which becomes granulomatous and then centrally necrotic by the 2nd week and usually clinically silent. Conversely, the Ghon complex is a combination of primary lung lesion, draining lymphatics, and ipsilateral lymph node involvement. Occasionally, the primary focus may enlarge, erode into bronchi, giving rise to the satellite with bloodstream (miliary tuberculosis). The term "miliary" arises from the similarity to innumerable "millet seeds" observed on CXR in cases of tuberculosis dissemination. The term Ranke complex is reserved to a Ghon complex undergoing fibrosis and calcification. • DDX: Other granulomatous infections of the lung. • TRT: The most common medications used to treat tuberculosis include isoniazid, rifampin, ethambutol, and pyrazinamide. • PGN: Although rare in high-income countries, miliary dissemination may become a reality, particularly in immunodeficient children. The increasing burden of pediatric TB in both foreign-born children and North Americaborn children of foreign-born parents suggests for more timely diagnosis of source cases. More effective and efficient screening of latent TB infection should be one of the primary tasks of the future.

Typical mycobacteria (e.g., M. tuberculosis, M. bovis, M. leprae) are 3-5-μm-long bacteria, which may be slightly wavy or beaded. Conversely, atypical mycobacteria (e.g., Mycobacterium avium intracellulare) are somewhat longer and thicker. The identification of mycobacteria can be very time-consuming. It has been advised to use thick sections, screen for 20 min at 40× and focusing up and down. Secondary TB usually arises from reactivation of old primary lesions creating progressive pulmonary TB, tuberculous empyema, intestinal TB, in case of swallowing of aspirated material, or miliary seeding. Isolated distant organ involvement includes extrathoracic lymph nodes, meninges, kidneys, adrenal glands, bones, fallopian tubes, testis, and epididymis. Secondary TB is usually accompanied by fever, night sweats, weakness, failure to thrive, fatigability, and loss of appetite. As historical notes, Heinrich Hermann Robert Koch (1843 Koch ( -1910 was a German physician and microbiologist. He is at the basis not only of the tuberculosis, but he is still recognized for paving the basis of clinical microbiology using his four postulates, including 1) the need of the microorganism to be always present in every case of the disease; 2) the need of the isolation of the microorganism from a host containing the disease and ability to grow in pure culture; 3) the need to prove a causative role for the microorganism taken from pure culture ro induce disease after inoculation into a healthy animal; 4) the need to have the same disease and same microorganism in the inoculated animal as first isolated from the primary diseased host. The date of March 24, 1882 is recorded as a milestone in clinical microbiology because that day Robert Koch announced to the Society of Physiology in Berlin Physiological Society that he had discovered the cause of tuberculosis. His presentation was followed by a scientific paper a few weeks later. His name is behind tuberculosis, cholera, and anthrax and received the Nobel Prize in Physiology or Medicine in 1905 for his research on tuberculosis. Mycobacterium avium intracellulare (special stains and culture), reactions to metals/minerals (clinical history, polarization field), hypersensitivity pneumonitis (loose granulomas with more cellular inflation), local sarcoidlike responses (as seen adjacent to neoplasms and in draining lymph nodes), Wegener granulomatosis (suppurative "dirty" necrosis with neutrophils and necrosis surrounded by palisaded histiocytes).

• TRT: In Nathan's study patient data were analyzed after a follow-up of 18 months and 4-5 years. In the <10 years group, 7 of the 14 patients recovered completely and were free of health-related problems from sarcoidosis, while three patients exhibited improved clinical manifestations. In 1/3 of the cohort, relapses were seen leading to an increase in steroid treatment and for three of them the introduction of immunosuppressive therapy (mycophenolate mofetil, hydroxychloroquine, infliximab, methotrexate, azathioprine, cyclophosphamide). In the 4-5-year follow-up, in the <10 years group, only 1/3 of the patients experienced transient relapses. In the ≥10 years group, declines were seen in about half of the patients with current treatment regimens including steroids (oral or IV), of which seven received immunosuppressive drugs. • PGN: 2/3 hilar sarcoidosis ⇒ spontaneous remission, but if lung disease is (+) ⇒ chronicity!

• DEF: Fungal infection due to Aspergillus spp. with three types of infection (Fig. 2.31 ). • EPI: Ubiquitous fungus.

• EPG: Aspergillus 2nd most common infective fungus, especially in hospitals with 45° angle branching ("Y"-branching) septate hyphae with standard thickness (~4 μm) (dichotomous branching) (≠ mucormycotic zygomycosis due to Rhizopus spp.) (vide infra). Aspergillus fumigatus is the most common class identified in all pulmonary syndromes. Aspergillus flavus is more often involved in several forms of allergic rhinosinusitis, postoperative aspergillosis, and fungal keratitis, while Aspergillus terreus, which is amphotericin B resistant, is often observed in IA (invasive aspergillosis) in some institutions. Occasionally, Aspergillus niger is seen in IA or aspergillus bronchitis. • CLI: Several forms mainly according to the immune system of the host, including invasive aspergillosis (IA), chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA) and aspergilloma as a late manifestation of CPA. • CLM: Basophilic hyphae (viable) and eosinophilic hyphae (necrotic) and conidia (spores) and conidiophores (fruiting bodies) can form and be observed in cavities. • DDX: Mucormycotic zygomycosis due to Rhizopus spp. shows irregularly branching aseptate/pauci septate hyphae of variable thickness (up to 20 μm) and random orientation with 90° angle branching and thinner than the stem (nondichotomous branching). Other two differential diagnoses are Pseudallescheria spp. (conidia differentiation) and fusariosis (90° branching). • TRT: Voriconazole is the antifungal agent of choice for treatment of IA. • PGN: It depends on the clinical form and the immune system of the host.

IA mainly affects patients with profound lifethreatening defects in immune function (e.g., hematopoietic stem cell TX or solid organ TX recipients, patients undergoing CHT or steroid treatment). The more indolent form of aspergillosis is the CPA, which affects patients with underlying lung disease (e.g., cystic fibrosis), but with no or only minimal generalized immune compromise. The third form, ABPA, implicates an allergic response to inhaled Aspergillus spp. and results in severe asthma with fungal sensitization and asthmatic crises. The aspergilloma is rounded cluster of fungal hyphae, mucus, fibrin, and cellular debris that originates in pre-set lung cavities that have become colonized with Aspergillus.

These lesions include the following etiologic categories: histoplasmosis, coccidioidomycosis, cryptococcosis, blastomycosis, dirofilariasis, pneumocystosis, mucormycosis, cytomegalovirosis, and adenovirosis. include severe airflow obstruction, inadequate capacity of physical activity, severely short of breath, significant over/underweight, respiratory failure, cor pulmonale, active smoking or continuous exposure to passive smoking, frequent acute exacerbations). The Reid mean value in healthy individuals is ~0.25 (~1/4 of the thickness of the wall between the surface epithelial basement membrane and the external perichondrium). In patients with chronic bronchitis as well as in patients with cystic fibrosis who may develop chronic bronchitis, Reid index is ~0.6.

• DEF: Abnormal permanent enlargement of the distal airspaces due to the destruction of the alveolar walls with rarefaction of the alveolar septs and definitive loss of respiratory tissue • EPG: There is a lack of elastic recoil, and the most common cause is smoking, which pro-

It represents the ratio of the thickness of mucous glands (MGT: mucosal glandular thickness) to a depth of the wall (WT: whole thickness) between the basement membrane of the surface epithelium and perichondrium.

Note: the blue bar is the cartilage, while the yellow circle is the cluster of the subepithelial mucous gland. inflammation, while alpha-1antitrypsin deficiency (AATD) produces almost pure emphysema. The use of vaping and electronic cigarette (e-cigarette) is increasing at a very alarming rate. Vaping is becoming more popular with youth in middle and high school. No or poor regulation and diffuse pseudoknowledge about safety have worsened the situation in the last few years. Vaping includes the term of e-cigarette or other vaping device. E-cigarettes are the battery powered devices that deliver a nicotine-containing liquid, which changes into a vapor when turning on the devices. Chronic e-cigarette use does increase the neutrophil elastase and matrix metalloprotease levels in the lung (Ghosh et al. 2019).

• CLI: 2 Major Types -Centroacinar (centrilobular) emphysema: Proximal parts of the acini (respiratory bronchioles) with sparing of the distal alveoli and more severe involvement in upper lobes, especially apical segments, observed in smoking and secondary to coal dust. Blue bloater-type: Severe effects due to shunting not compensated ⇒ ↑ CO 2 Hypercapnic respiratory failure (e.g., pulmonary HTN, cor pulmonale) -Panacinar (panlobar) emphysema: Uniform enlargement of all acini in a lobule without sparing of any portion and more severe involvement of the lower lobes, observed in AATD -Pink puffer-type: Milder effects with compensation by ↑ ventilation ⇒ ↓ CO 2

Other types include the paraseptal variety (distal acinar involvement with normal proximal acinus and most prominent adjacent to pleura and along the lobular connective tissue septs as observed in adolescents and youth with spontaneous PNX). Moreover, there are also the bullous type (any form of emphysema which produces large subpleural bullae with Ø > 1 cm), interstitial type (air penetration into the connective tissue stroma of the lung, mediastinum, or subcutaneous tissue), and the compensatory type (pseudo-emphysematous dilatation of alveoli without destruction of septal walls in response to loss of lung tissue). The senile type (pseudoemphysematous change in lung geometry with larger alveolar ducts and smaller alveoli without loss of lung tissue) does not play any role in childhood or youth unless we consider the progeria syndrome and progeroid conditions.

The concept that pneumoconiosis is diseases of the adult is probably not valid anymore. There are still vast geographical areas, where asbestos is still part of the production, and children of poor-developed countries may suffer from the exposure to asbestos due to the contact with dresses and wearing used from parents and relatives. This aspect may also be real for other mineral or organic dusts as emphasized in most recent reviews (Box 2.18). Typically, silicosis is a disease of long latency affecting mostly older workers, but silicosis deaths in young adults (aged 15-44 years) implicate acute or accelerated disease. In 2017, CDC (Centers for Disease Control and Prevention) published a report which analyzed the underlying and contributing causes of death using multiple cause-of-death data (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) and industry and occupation information abstracted from death certificates (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) . CDC identified 55 pneumoconiosis deaths of young adults during 1999-2015. They used the International Classification of Diseases, 10th Revision (ICD-10) code J62 (pneumoconiosis due to dust containing silica). Of the 55 pneumoconiosis deaths in youth, 38 had pneumoconiosis due to other soil containing silica, and 17 had pneumoconiosis due to talc dust. Decedents worked in the manufacturing and construction industries Box 2.18 Adult Pneumoconiosis of the Youth 2.11.1. Silicosis 2.11.2. Asbestosis 2.11.3. Non-silico-Asbestosis-Related Pneumoconiosis and production occupations where silica exposure occurs. The 17 deceased adolescents and young people had an underlying or a contributing cause of death listed that indicated multiple drug use or drug overdose, but it does not seem that their talc-related death was occupational because none was working or was exposed in talc exposureassociated jobs. Mesothelioma is rare cancer most commonly diagnosed in people in their 60s and 70s, but over 300 cases of mesothelioma have been reported worldwide in young adults, children, and even infants. There is plenty of literature that in most cases of mesothelioma diagnosed in childhood and youth, there is no clear-cut family or personal history of exposure to asbestos differently from the adult cohorts, but the publications are often missing a proper environmental incidental report. In fact, most exposures to asbestos may come from the environment or exposure from fathers or mothers working in asbestos exposurerelated job companies and bringing the working dress home. Secondhand exposure from a parent who worked with asbestos is a very critical cause in mesotheliomas of childhood and youth. Moreover, asbestos is still present in schools, and environmental asbestos is still a significant burden today because children can breathe the air or play in or eat contaminated soil. Asbestos in toys such as chalk, crayons, and modeling clay may be an additional factor (Fig. 2.32 ).

• Silica associated lung disease: SiO 2 (e.g., quartz). The main steps of the iterative cycle of pneumoconiosis include direct cellular toxicity, production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and inducible nitric oxide synthase, secretion of inflammatory and fibrotic mediators, lung remodeling through collagen and elastin deposition, and programmed cell death with release of indigestible silica. Freshly fractured elements of silica stimulate mitogen-activated protein kinase (MAPK) family members, as was proved by Ding et al. (1999) evidencing the phosphorylation of p38 MAPK and extracellular signalregulated protein kinases 2.11 "Adult" Pneumoconiosis of the Youth • Acute silicosis ("accelerated silicosis"): Heavy exposure over 1-3 years with a pulmonary alveolar proteinosis-like appearance with variable amounts of interstitial fibrosis. • Chronic silicosis: Pneumoconiosis following 20-40 years exposure to dust containing up to 30% quartz. Activities with mining, sandblasting, metal grinding, tunneling, and ceramics are at risk. There is a highly debated frame of progression with regards to the years after exposure and subsequent proliferation of hyalinized nodules and the reality is that there are individual and environmental factors that may play an important role. Chronic silicosis usually prefers the peripheral areas at the upper lobes. There may be variable amounts of black pigment (concomitant exposure to coal dust), well-delimited, concentric lamellated hyaline, with rare MNGC or granulomas and rare fields with necrosis. Finally, an expansion of the nodules with obliteration of the small airways does eventually occur. • CLM: Whorled laminar collagen with doubly birefringent refractile round particles (1-2 μm) and peripheral plasma cells ⇒ silicotic nodules ⇒ conglomeration (obliteration of the small airways), which is often responsible for the final lung insufficiency. • PGN: Complications -TB (in average 20× increased risk to contract this infection; 10-30× relative risk as a common range in numerous institutions involving individuals of different age).

In childhood, silicosis due to secondary exposure can occur and particularly among the children of mining communities in India. Unfortunately, malnourishment, tuberculosis, and silicosis are co-morbid conditions, especially in vulnerable populations like children who live close to stone mines. Important works of the American Academy of Pediatrics (AAP), Section on International Child Health (SOICH), in advocating more heath for children worldwide are key. Children are especially susceptible to silicosis from nonoccupational exposure in stone-mining areas where (a) communities are impoverished and have little access to modern medical facilities, (b) families live close to the workplace, and casual child labor is common, and (c) mine owners do not take preventive measures. Although mine owners do not comply with legislation to protect the health and safety of workers, particularly in some geographical areas, the state continues ignoring this situation as the stone-mining industry generates much foreign exchange, and there is limited legislative protection for families from subsequent exposure.

Clinicopathologic diagnosis requiring histological confirmation with (1) diffuse interstitial fibrosis of the asbestosis type and (2) evidence of asbestos as the etiology (asbestos bodies).

1. Interstitial fibrosis of at least grade 3 or grades 1-2 with a typical distribution. Asbestosis typically manifests in the lower lobes with irregular "reticular" markings on CXR toward the lung periphery and involves the costophrenic angles with subpleural accentuation.

-Identifiable when ferruginated as golden foreign bodies using PPB (Pearls Prussian Blue histochemical special stain) -Located in the walls of the respiratory bronchioles and associated with intraalveolar Mф -Significance level when >1 AsBd in ≥1-5-μm-thick PPB-stained lung tissue section from ≥1 several FFPE lung tissue blocks (standard: 1 AsBd/100 sections; FFPE, formalin-fixed and paraffin-embedded) (it has been proposed to have 30-μm-thick sections to reduce the time to find asbestos bodies, but it is not feasible at all times) -Quantification also in BAL and TEM -TEM evaluation: The reference values are roughly 1-2 × 10 6 fibers·g −1 dry lung for total amphibole fibers and 0.1 × 10 6 fibers·g −1 for amphibole fibers longer than 5 μm. -Asbestos-related pleural plaques (macronodular and microscopic "basket-weave" collagen)

-Compensation is foreseen for asbestosis, diffuse pleural fibrosis, or asbestos-related neoplasm (malignant mesothelioma and any lung carcinoma).

• DDX of asbestos-related pleural fibrosis include: -Sarcomatoid mesothelioma -Tuberculosis -Connective tissue disorders -Lung adenocarcinoma

Interstitial fibrosis similar to UIP, beginning as peribronchiolar fibrosis, preferentially lower lobes, with pleural fibrosis/calcification, parietal pleural plaques. The grading of the severity is related to the fibrosis.

• PGN: Progressive massive fibrosis and "new" Caplan syndrome. There is a ↑ risk of bronchogenic carcinoma -risk relative to unexposed is 5× (relative risk for smokers, 11×; relative risk for smokers exposed to asbestos, 55×). Asbestos exposure increases unavoidably the risk for mesothelioma (both pleural and peritoneal), although the non-bronchogenic mesothelioma is still more rare than bronchogenic mesothelioma.

Simple CWP does present after years of exposure to coal. Two definitions are useful. Dust macule is defined as interstitial dust-filled MΦ surrounding dilated respiratory bronchioles and in the interlobular septa, usually affecting the upper portions of lobes, with minimal fibrosis, while coal nodule is defined as discrete palpable <1 cm (Ø) lesion with central hyalinized collagen and pigment-laden MΦ.

Pulmonary mycotoxicosis or organic dust syndrome is caused by massive inhalation -probably toxic vs. immune bronchiolitis with intra-alveolar and interstitial neutrophils. Siderosis occurs following exposure to inert metallic iron or its oxides. There are macules and perivascular dustlike CWP but with coarse brown-black particles of Fe and gold-brown hemosiderin. Berylliosis in the acute form produces DAD, while the chronic forms a systemic disease with a latent period up to 15 years. Most often, there is interstitial fibrosis with non-caseating subpleural, peribronchiolar, and perivascular granulomas which may have Schaumann bodies or asteroid bodies like sarcoidosis (vide supra). Other agents include talc, aluminum powder, hard metal pneumoconiosis, alginate powder, polyvinyl chloride, and fibrous glass.

In this category, we list the vascular disorders as shown in Box 2.19. Notes: Necrotizing capillaritis is substantially the basis that is present in microscopic polyangiitis (MPA), Wegener granulomatosis (WG), systemic lupus erythematodes (SLE), but also CSS/EGPA although it is less frequently observed in this entity (Churg-Strauss Syndrome/Eosinophilic Granulomatosis with Poly-Angiitis).

Pulmonary congestion is a hemodynamic increase of hydrostatic pressure (e.g., Starling law), as seen in congestive heart failure showing blood-filled blood vessels and capillaries full of blood. Ernest Frankling is probably the most influential personality in cardiac physiology studying the hemodynamics of heart failure (Patterson and Starling, 1914) . The harbinger, Frank Starling, tectonically demonstrated that stroke volume increases proportionally with end diastolic volume (preload). This phenomenon is epitomized as "Frank-Starling Law". This principle allows the heart to actively compensate for impaired contractile function and can be a forewarning of the clinical syndrome of heart failure. Pulmonary edema is the extravasation of fluid into interstitium (interstitial edema) and, then, into alveoli (alveolar edema) due to either from hemodynamic disturbances (hemodynamic or cardiogenic pulmonary edema, usually left-sided congestive heart failure for mitral insufficiency or hypoplastic left heart, HLH) or direct increase in capillary permeability. Grossly, wet and heavy lungs are seen with fluid coming out on the dissecting table at the time of the cutting of the lungs in two halves. The intra-alveolar fluid occurs only after lymphatic drainage has increased by about tenfold and is more prominent in the lower lobes and potentially accompanied by alveolar micro-hemorrhages and hemosiderin-laden Mϕ ("heart failure cells" or "Herzfehlerzellen" of the German literature). In situations when a longstanding process of lung congestion occurs, the wet and heavy lungs become firm and assume a brown coloration, a process called "brown induration" of the lungs. It should be pondered that all these changes of the hemodynamics in the lung predispose to infection, other than impair normal respiratory function. This is quite often the case of the increased risk of contamination of children with HLH treated with Norwood procedure, bidirectional Glenn anastomosis, and hemi-Fontan procedure before a TX organ may become available. The Western Canadian Heart Transplantation Program is leading in research and clinics in North America and worldwide with institutions and laboratories located at the Mazankowski Institute and University of Alberta, Edmonton, AB, Canada. An increased number of hemosiderin-laden Mϕ occur in infants with sudden infant death syndrome (SIDS) and sudden unexpected death in infancy (SUDI), although markedly increased hemosiderin-laden Mϕ has been associated to a nonnatural death. Microvascular injury may occur by inflammation, infection, toxins, and shock, and when diffuse, the acronym ARDS for acute respiratory distress syndrome is used as a diagnosis. Regarding acute lung injury (ALI) is summarized as a spectrum of pulmonary lesions played on an endothelial and epithelial level that can be initiated by some factors. ALI may present as congestion, edema, surfactant disruption, and atelectasis. ALI may be transitory or progress to ARDS or acute interstitial pneumonia/-itis.

Rudolf Virchow's triad is still actual and part of one of the bases of teaching. It consists of vascular damage, slowdown of the circulation (rouleaux), and abnormality of the coagulation which can induce thrombosis.

It occurs as occlusion of pulmonary arteries by a blood clot, which is almost always embolic in the source. In 95% of cases, thrombi from deep veins of the legs may cause death not only in the elderly but also in adolescents and even children. Large emboli (e.g., saddle embolus) often cause sudden death. If no sudden death is recorded, the clinical picture may resemble myocardial infarction. If the patient survives, the clot may retract and eventually become lysed, leaving only small membranous webs. Infarction most commonly involves the lower lobe (75%), with a wedgeshaped pleural-based lesion, hemorrhagic at first, but then becomes pale as red cells lyse and fibrous replacement begins (at the edges) ( Fig. 2.33) . 

Pulmonary arterial pressures are, usually, only 1/8 of systemic arterial pressures. Atherosclerotic changes may be seen in pulmonary arteries in case of long-standing permanent hypertension and are generally indicative of pulmonary hypertension. The etiology is protean. Most probably, the most systematic and straightforward approach is to proceed along the cardiopulmonary pulmonary circulation, differentiating the causes that are found at each site. In 2003, the 3rd World Symposium on primary PAH updated the classification system in Venice, Italy (Fig. 2.34) .

The normal conditions reveal that the pulmonary arterial pressure is 25 mmHg at rest and 30 mmHg during exercise. The arteries have an internal and external elastic lamina, and the muscle wall thickness is up to 7% of the external diameter. The veins characteristically travel in interlobular septs and have indistinct muscle and elastic laminae, while arterioles and venules have a single elastic lamina and lack muscle. Collateral arteries branch directly from larger arteries into the respiratory parenchyma and represent the typical site of dilatative and plexiform lesions. To increase the reproducibility of studies on PAH, pulmonary BVs need to be measured with an internal caliper properly. Using an electronic caliper to measure the inner diameter (ID), the external diameter (ED), and the adventitial diameter (AD), vascular morphometric parameters including relative adventitial thickness (%AT), relative media thickness (%MT), and wall thickness (WT) are calculated congruously. The arterial wall thickness (WT) is calculated as WT = (ED − ID)/2. The relative medial thickness (%MT) is defined as %MT = (ED − ID)/ ED * 100 and relative adventitial thickness (%AT) as %AT = (AD − ED)/ED * 100 in consideration that we talk about percentage change. If V 1 represents the old value and V 2 the new one, percentage change = ∆V/V 1 = V 2 − V 1 /V 1 * 100 and some devices directly support this calculation via a %CH or ∆% function (Box 2.20). When the variable in the query is a percentage itself, it is better to readdress its change by using percentage points, to avoid confusion in the reader between relative difference and absolute difference. In every lung, RAC also needs to be determined and added to the studies of PAH because a degree of lung maturation will help to understand the substrate for pulmonary hypertensive changes. In PAH investigation, it is advisable that RAC is usually measured in 20 different places to include the entire surface of the evaluated lung specimen. Vascular measurements are performed on 10 peripheral pulmonary arterioles. All these measurements need to be combined to calculate means and standard deviations, and t-test and ANOVA statistically compare the results.

Primary arterial hypertension is characterized by the occurrence in young females, involvement of liver disease, connective tissue disorders, infections (e.g., HIV), drug exposure, eosinophilia, parasitosis, and medial and intimal thickening. Conversely, primary venous hypertension occurs in a setting of bone marrow transplantation, chemotherapy, and radiotherapy. It may be secondary to arterial hypertension without plexogenic pulmonary vasculopathy. Primary venous hypertension is characterized by thrombosis and recanalization of septal veins with local congestion and intimal fibrosis, septal fibrosis, capillary hemangiomatosis, and granulomas to Fe/Ca deposits in the elastic laminae.

Secondary arterial hypertension is often due to ILD and chronic hypoxia with thrombotic and thromboembolic characters. Secondary venous hypertension is due to acquired CVD, mediastinal disease, sarcoid with venous medial hypertrophy and arterialization, and hemosiderosis are the main etiologic factors. Lymphangiectasis, septal edema and fibrosis can occur. The Heath-Edwards grading is an evaluation of the pulmonary vascular alterations, introduced by Heath and Edwards (1958) . It has been widely used for assessment of the severity of the hypertensive disease of the pulmonary blood vessels. However, a lot of criticisms has been raised pointing to the increasing awareness of the complexity of the vascular lesions, and Wagenvoort (1981) suggested that this grading system no longer fulfills the requirements of unambiguous evaluation of the severity of vascular disease. Wagenvoort (1981) eventual decrease in number and size of vessels should all be assessed for all blood vessels, not only for the arteries. However, the Heath-Edwards grading is still a good standard in PICUs and cardiology departments because it is easy to perform and has a good ratio of inter-and intraindividual variability. In the Heath-Edwards grading, grades I-III are considered potentially reversible, while categories IV-VI are usually regarded as irreversible about the prognosis of patients harboring hypertensive pulmonary vascular disease. The plexiform lesions are vascular endothelial growth factor (VEGF)-1+ and show cellular recanalization-like plugs but with proximal local cellular intimal thickening, distally dilatative injuries, occurring at supernumerary arterioles and need to be differentiated from thrombotic or embolic recanalization sites, which show no dilatative injuries and usually affect larger blood vessels. Veno-occlusive disease is depicted in Fig. 2 .35.

In the case of bone marrow transplantation, pulmonary complications may occur in ~50% of patients. These are usually of infectious origin (bacteria) with lobar pneumonia or interstitial pneumonia/its but may also involve the bronchioles (obliterative bronchiolitis) or the bronchi (lymphocytic bronchitis). In the setting of heart-lung transplantation, 50% develop obliterative bronchiolitis after a mean interval of 10 months, and there is a 50% mortality -probably due to chronic reject.

The 2007 Working Formulation for the Standardization of Nomenclature in the diagnosis of lung rejection is followed (Fig. 2.36) . Grade 0 has no mononuclear inflammation, hemorrhage, or necrosis. Grade 1 (minimal) shows infrequent (scattered) perivascular 2-3-cell-thick mononuclear infiltrates in the alveoli of the lung parenchyma, but no eosinophils and no endothelialitis. In grade 2 (mild), there are frequent perivascular 2+ cell-thick mononuclear infiltrates (lymphocytes, plasmacytoid lymphocytes, MΦ, and eosinophils) and endothelialitis, but no apparent infiltration into the adjacent alveolar spaces/airspaces. In grade 3 (moderate), there are readily detectable perivascular 2+ cell-thick mononuclear infiltrates (lymphocytes, plasmacytoid lymphocytes, MΦ, and eosinophils) and endothelialitis, with apparent infiltration into the adjacent alveolar spaces/airspaces. Finally, grade 4 (Severe) shows an architecture with diffuse perivascular, interstitial, and intra-alveolar mononuclear infiltrates (lymphocytes, plasmacytoid lymphocytes, MΦ, and eosinophils) with pneumocyte damage, endothelialitis ± intra-alveolar necrotic cells, MΦ, hyaline membranes, bleeding, and PMNs and with or without parenchymal necrosis, infarction, or necrotizing vasculitis.

There are morphological features of chronic rejection that are common to all solid organ allografts. These features include (a) patchy organized interstitial inflammation, (b) patchy interstitial fibrosis and associated atrophy of the parenchyma, (c) graft vascular disease with initial fibrointimal hyperplasia of arteries, (d) destruction of epithelial-lined ducts, and (e) destruction and atrophy of organ-associated lymphoid tissue and lymphatic channels. The immunological injury seems to play a primary role in the initiation and progression of these lesions. The final phenotypic expression of chronic rejection is dependent on an interaction between immunologic and physiologic factors that results in the prevalence of one 

The interpretation of fibrosis in histologic glass slides as well as the digital file may be quite challenging and harbor quite a considerable interindividual and intraindividual variability. Thus, the use of objective methods may be quite desirable. IBAFIS is the acronym for a procedure performed in our laboratories at the University of Alberta Hospital. The following data may explain the sys-tem in detail. First, the histologic slide is stained with Masson's trichrome, then the stained slide is scanned with some software (e.g., Aperio TM ), or three fields are identified by random numbers using a random number generator coupled with a positional field determining machine. The following equations are considered crucial for the determination of fibrosis: area (total) = area (cells) + area ICM dense + area ICM loose + area (empty space). Area ICM dense is the area corresponding to fibrosis. Thus, it results from subtracting the cellular area, the free ICM area, an area constituted by space from the total area. There is not only a sign of hemorrhage on the left side of the photograph but the change of the color of the lung in other fields of the gross photograph. Microphotograph (b) shows an acute rejection A1 (hematoxylin and eosin staining, ×100 original magnification). Figure (c) shows an A2 acute rejection (hematoxylin and eosin staining, ×100 original magnification). Figure (d) shows another aspect of the lung rejection with a lymphocytic infiltration, which is not only interstitial but also perivascular (hematoxylin and eosin staining, ×100 original magnification). Figure (e) another example of lung rejection (A2 cellular rejection) (hematoxylin and eosin staining, ×200 original magnification). The microphotograph (f) is an immunohistochemical detection of A2 cellular rejection performed using an antibody against CD3 lymphocytes highlighting the infiltrating lymphocytic population (anti-CD3 immunostaining, avidin-biotin complex, ×100 original magnification). Figures (g) and (h) show the histology of severe rejection (A3 cellular rejection) (hematoxylin and eosin staining, ×200 original magnification) (see text for details) variant of the IBAFIS is the IBANIS, which is the ImageJ-based automated nuclear index score. This last score may be necessary to identify the increase of the nuclear size of the cardiomyocytes in case of hypertrophic cardiomyopathy.

In this category, only very few pathologies may be encountered in childhood or youth. It is indeed challenging sometimes to distinguish between benign and malignant neoplasms because some benign tumors can behave very aggressively in the postsurgical course or follow an open lung biopsy and some tumors classified as lethal may have a better outcome if resection was performed entirely and staging does not show any metastatic colonization. In Box 2.21, the most frequent pediatric tumors and pseudotumors are listed and will be part of the topic of this chapter. In childhood, pleuropulmonary blastoma and carcinoid (NE, neuroendocrine) tumors play the significant role, but small cell carcinoma, adenocarcinoma, squamous cell carcinoma, as well as mucoepidermoid carcinoma can be encountered but will be discussed in the "adult"-type malignant primary neoplasms of the lung (Box 2.21). Some pathways involved in lung carcinogenesis are depicted in Fig. 2 .37a.

Intrathoracic teratomas are typically seen in the mediastinum, but occasionally they arise in the pulmonary parenchyma as intrapulmonary teratomas ( Fig. 2.37b, c) . The criteria for the diagnosis of an intrapulmonary teratoma are the exclusive origin of the tumor from the lung and exclusion of a gonadal site or other extragonadal primary sites. Histologically, PUT is similar to other benign cystic teratomas that have endodermal, mesodermal, and ectodermal tissue elements of the primitive three germ cell layers. At places, a malignant component can be seen, including primitive neuroectodermal tumor, Wilms' tumor, neuroblastoma, or carcinoma that upstage the tumor. The presence of squamous differentiation and mature cartilage is observed in numerous cases. The presence of neuroectodermal tissue portends to the diagnosis of immature teratoma. Since PUT can have pancreas tissue and other endodermal elements, digestive or proteolytic enzymes can be secreted by the tumor that make the teratoma prone to rupture.

In childhood, solid lung masses are typically caused by underlying inflammatory, infectious, or reactive processes. A plasma cellular infiltration may occur in the setting of chronic inflammation but also in the environment of a posttransplant lymphoproliferative disorder (PTLD) (Fig. 2. 37d, e) (vide infra).

The plasma cell granuloma (aka fibroxanthoma and histiocytoma) is often an incidental finding on CXR and occurs in childhood and youth. It shows mature plasma cells and lymphocytes in a background of fibrosis and granulation tissue. Another pseudotumor is the pseudolymphoma, which is similar to LIP. It is a residuum of a healing inflammatory lesion. There is a nodule, which replaces a portion of the lung parenchyma and shows scarring in the center with densely packed collagen, fibroblasts, and lymphocytes but no necrosis at the periphery.

In childhood and youth, intrapulmonary solid lung masses constituted by a heterotopic tissue are defined as hamartomas. In teratoma (vide supra), a germ cell layer differentiation different from autochthonous proliferation is seen. Atypical carcinoid (moderately differentiated NE tumors) is defined by an MI of 2-10/10 HPF (Ki67/MIB1, 10-48%) ± necrosis (criteria, ≥2 criteria of MI ≥ 5/10HPF, focal necrosis, some pleomorphism, and some focal loss of the architecture). Clinically, the atypical carcinoid lacks the SmCC chemosensitivity (5-YSR: 60%), and in about 2/3 of cases, metastases are found. Histologically, the nuclei show a more coarsely granular/vesicular chromatin pattern and variable nucleoli. It has been suggested that peripheral tumors with SmCC-like cytology are likely to be atypical carcinoids. The first differential diagnosis is SmCC (Fig. 2.38 ).

• DEF: A neoplastic disease that affects lungs, kidneys (angiomyolipoma), and the lymphatic system, characterized by haphazard proliferation of smooth muscle cells ("LAM cells") throughout the interstitial space involving the a b c d

This panel shows an inflammatory myofibroblastic tumor, which is an extremely rare type of pseudotumor that occurs most commonly in children and young individuals. Figure (a) shows the gross image of the tumor. The tumor is firm, gray-white, and quite homogeneous (a). The microscopic examination reveals proliferation of spindle cells arrayed in fascicles and admixed with lymphocytes, plasma cells, and eosinophils (b, hematoxylin and eosin staining, ×100 original magnification; c, hematoxylin and eosin staining, ×50 original magnification; d, hematoxylin and eosin staining, ×200 original magnification). The four immunohistochemical microphotographs (e-h) show the positivity of the tumor for CD138 or syndecan-1 (a plasma cell marker), actin (cytoskeleton antigen), Bcl2 (anti-apoptotic cell marker), and Ki67 (cell proliferation antigen) (e, anti-CD138 immunostaining, ×50 original magnification; f, anti-actin immunostaining, ×200 original magnification; g, anti-Bcl2 immunostaining, ×200 original magnification; h, anti-Ki67 immunostaining, ×100 original magnification). All immunostainings have been performed using the avidin-biotin complex. This tumor may be considered a true neoplasm because of the presence of the fusion gene anaplastic lymphoma kinase (ALK) 1 observed in the myofibroblastic component. The ALK gene, a tyrosine kinase oncogene, which is located on chromosome 2p23, was initially found to be arranged in anaplastic large cell lymphomas. This gene fusion leads to constitutive overexpression of the ALK determining cell proliferation in over half but not all inflammatory myofibroblastic tumors walls of blood vessels, lymphatics, bronchioles, and septa ( Fig. 2.39 ). • EPG: 2 forms -(1) inherited form, which is associated with tuberous sclerosis complex (TSC1 and TSC2 genes) and (2) isolated or sporadic form. • EPI: ♂ < ♀ (often women of childbearing age).

• CLI: Dyspnea, chest pain, cough, hemoptysis, spontaneous PNX, and chylous effusion. • CLM: Overgrowth of abnormal smooth muscle-like cells ("LAM cells") of endotheliallined structures with the tendency to give rise to the cystic formation and the consequent destruction of healthy lung tissue and chylothorax. • IHC: αSMA (+), HMB45 (+) (PEComa), S100 (−). • DDX: UIP (end stage), which can show smooth muscle proliferation. • TRT: Progestagens.

• PGN: Progressive disease ("neoplastic") unless therapy (or menopause) is started. LAM cells are cells that may spread between tissues and recur after lung TX.

• DEF: It is a diffuse proliferation of abnormal, complex lymphatic channels that may involve a lobe, part of a lung lobe, or the entire lung and often accompanied by chylous pleural effusions with tendency to unstoppable progression and dramatic fatality from respiratory failure. • EPI: Rare, children and young adults, ♂ = ♀.

• EPG: Congenital, possibly from abnormal lymphatic development. • CLI: Dyspnea, wheezing, and cough, which may be misinterpreted as bronchial asthma, but the diagnosis may be made if imaging (bilateral ground-glass opacities with smooth thickening of interlobular septa and bronchovascular bundles) is characteristic and bone is involved. • GRO: Tumor with subpleural and septal thickening. • CLM: There is a diffuse proliferation of complex, anastomotic lymphatic channels without significant dilatation, lined by benign appearing, flattened endothelial cells, as well as the prominence of lymphatic channels in visceral pleura, interlobular septa, and bronchovascular bundles with surrounding bundles of spindle cells, interspersed collagen, and blood vessels. Acellular, eosinophilic, proteinaceous material may be present in lymphatic channels. A hemorrhagic "kaposiform" component, with compressed vascular channels, plump spindle cells, and hemosiderin deposition, may be present. 2.14 Pediatric Tumors and Pseudotumors localized disease ± pleurocentesis, pleurodesis, pleurodectomy, and ligation of thoracic duct ± successful lung TX. • PGN: Worse prognosis for children than adults and pleural involvement is an adverse prognostic factor.

• DEF: Rare, primitive primary neoplasm of the thorax of young children, frequently associ-ated with cystic lung lesions arising in pulmonary parenchyma, mediastinum, and pleura with three subtypes of PPB (I, II, III) ( Fig. 2.40 ). • SYN: Pneumoblastoma, mesenchymal cystic hamartoma, cystic mesenchymal hamartoma, pulmonary rhabdomyosarcoma (misnomer), rhabdomyosarcoma in lung cyst (misnomer), and pediatric pulmonary blastoma. • EPI: Childhood, mostly 1st infancy (type I), while types II and III also older than 2 years of age. 

In childhood, solid lung masses are typically caused by Ewing sarcoma, osteosarcoma, or hepatoblastoma (Figs. 2.41, 2.42, and 2.43 ). These neoplasms are described in the soft tissue, arthro-skeletal, and liver chapter, respectively. Finally, the condition of lymphangiosis carcinomatosa should be mentioned. Lymphangitis carcinomatosa is extremely rare in childhood. It is an inflammation of the lymph vessels (lymphangitis) caused by an epithelial or mesenchymal malignancy. In adults, breast, lung, stomach, pancreas, and prostate cancers are the most common neoplasms that may result in lymphangitis carcinomatosa. However, Chiang et al. (1991) reported on an 18-year-old adolescent male, who was admitted due to acute respiratory failure. Bilateral fine reticular densities and right massive pleural effusion were seen in his CXR. Autopsy findings included pulmonary lymphangitis carcinomatosa arising from an adenocarcinoma of choledochal cyst with global dissemination. Originally, lymphangitis carcinomatosa was first described in 1829 by Gabriel Andral, who was a pathologist investigating a patient with uterine cancer.

In this paragraph, we focus on a quite problematic issue, the onset of adult-type lung neoplasms in childhood and youth. These neoplasms are very rare, but the modern therapy and new chemotherapy protocols and immunosuppressive drugs have suggested pediatric oncologists and pediatric pathologists to discuss on this category in pediatric and pediatric pathology textbooks. The issue is problematic because there is the risk of misdiagnosing some of these entities because these neoplasms are non-familiar to pediatricians and pediatric pathologists. Thus, the review of the literature is essential first to highlight the rise of this concern and second to look at the new classification criteria that have been consolidated in the last couple of years in pediatric respiratory medicine (Box 2.22) (Fig. 2.44 (MEC) . Typically, they have a quite favorable prognosis. Lung cancers which are common in adults, but rare in children, have a worse prognosis in this age group. The histologic types of tumors encountered are similar to lung tumors occurring in adults, although the frequency of the vari-ous kinds differs from series to series. Carcinoid tumors are more frequent than bronchogenic carcinoma of small cell type. Carcinoids are also prevalent in the pediatric age group. Similar to the adult population, the prognosis of these tumors is dependent on histology and stage. Patients with carcinoid tumors seem to have the best outcome, followed by adenocarcinoma. The highly aggressive basaloid carcinoma has the worst sequel. The preinvasive lesions may develop early in the youth, particularly in patients with genomic mutations of tumor suppressor genes or in young adults who started smoking cigarettes early in life, as seen in some countries. It is uncertain the role of the diffuse use of cannabis in the young generations about pulmonary oncogenesis. Smoked marijuana has deleterious effects on nerve cells, but most probably has also a role in inducing/promoting the carcinogenesis of lung tumors as identified in several studies eliminating confounding factors, such as tobacco and alcohol. About the outcome and the therapeutic protocols, it is now known that some recom-mendations have become compulsory in some countries. This aspect may be the case for the youth living with an adult-type bronchogenic carcinoma as well. Pathologists, oncologists, pulmonologists, methodologists, and laboratory scientists, including molecular biologists as well as patient representatives, collaborate constantly to develop new guidelines. In addition to the 2013 recommendations of the College of the American Pathologists, new genes have been suggested to be investigated in case of an NSCLC regardless of the age of the patient. The following tests are now recommended:

1. EGFR and ALK mutation testing 2. ROS1 mutations EGFR T790 M mutational testing is essential to perform in patients who have progressed after tyrosine kinase inhibitor (TKI) treatment with a 1st-/2nd-generation EGFR TKI therapy, while ROS1 mutation is a new and strongly recommended investigation to be carried out for all lung cancer patients independently of clinical characteristics. Moreover, ALK immunohisto- Inhibition of tumor cell apoptosis and ultimately tumor progression occurs in case of an improper activation of EGFR TK (gain-of-function or activating mutations). Moreover, EGFR interacts with the integrin pathway and activates matrix metalloproteinases to modify cellular adhesion, motility, and invasion into the surrounding environment. The activation of EGFRdependent intracellular signaling is not the only mechanism, but several pathways have been identified in pulmonary carcinogenesis. HER 2 or sometimes called ERBB-2 is a transmembrane tyrosine kinase receptor. HER2 gene mutations occur in around 1-5% of NSCLC, and gene variations involve most often in-frame insertions in exon 20, which codes part of the kinase domain.

As EGFR mutation, the frequency of HER2 mutations has been demonstrated to be increased in adenocarcinoma, never smokers, women, and Asian patients. ALK is a critical member of the insulin superfamily of receptor TK and is usually expressed only in the CNS, small bowel, and testis. Initially, the ALK gene translocation, t(2;5) (p23;q35), was found in a subset of anaplastic large cell lymphomas in the mid-1990s, while fusions of ALK with another upstream partner, EML4, were found in NSCLC more than 10 years later. EML4-ALK fusions result in protein oligomerization, and constitutive activation of the kinase causes aberrant activation of downstream oncogenic signaling pathways such as MAP kinase, PI3-kinase, and signal transducers and activators of transcription (STAT). EML4-ALK fusion is unusual, occurring in ∼3-7% of patients with NSCLC and is more prevalent in individuals who never smoked or in light smokers and patients with adenocarcinoma and is commonly mutually exclusive with EGFR or KRAS mutations and associated with resistance to EGFR TKIs. KRAS has a key role in the EGFR signaling network and appears activated through a mutation in ∼5-30% NSCLC. The exon 2 and codon 12 or 13 occur frequently (NSCLC, 97%). These missense mutations impair the functionality of RAS GTPase, locking the RAS signaling in active mode. Mutations of RAS occur predominantly in "smoking adenocarcinoma" patients, but 15% of never smokers with adenocarcinoma also have transition mutations [G → A (purine for purine)]. An activating mutation of KRAS is present in ∼25-35% of TKI nonresponsive cases; somatic mutations of the KRAS oncogene are highly specific negative predictors of response to single-agent EGFR TKIs in advanced NSCLC, mostly adenocarcinomas. EGFR and KRAS mutations are hardly detected in the same tumor.

The BRAF gene encodes a protein (a cytoplasmic serine/threonine kinase) that has a key role downstream of KRAS in cell signaling pathway. B-RAF is one of the three crucial members of the RAF kinase family (A-RAF, B-RAF, and RAF-1/ c-RAF). BRAF gene mutations are associated with ↑ kinase activity that leads to activation of the downstream pathway. BRAF gene mutations are found in 1-3% of lung cancers (adenocarcinomas, usually) and appear in a mutually exclusive pattern with KRAS and EGFR gene mutations. PIK3CA mutations are seen in ∼1-5% of NSCLC and appear more often in squamous cells. PIK3CA mutations most frequently affect residues Glu542 and Glu545 in exon 9 and 20 encoding the helical and catalytic domain.

PIK3CA copy number gains occur in approximately 20-30% of lung cancers, with higher frequency in SqCCs. The AKT1 gene encodes protein kinase B, which helps to mediate PI3K signaling. The AKT1 E17K mutation was found in 1% of SqCC of the lung but not in pulmonary adenocarcinoma. The phosphatase and tensin homolog (PTEN, located on 10q23), a tumor suppressor, encodes a lipid phosphatase that negatively regulates the phosphatidylinositol 3-kinase/ AKT pathway. It dephosphorylates PIP3 into phosphatidylinositol-3,4-bisphosphate (PIP2), thereby inhibiting PI3K-AKT signaling. The loss of PTEN activity leads to hyperactivation of the PI3K-AKT pathway. PTEN inactivation, which can occur at the genomic level or the protein level, becomes apparent typically through epigenetic mechanisms. Promoter methylation is found in about 1/3 of PTEN-negative NSCLC, both adenocarcinoma and squamous cell. It has been proved that neoplasms with PTEN loss may be more sensitive to inhibitors of the PI3K pathway. MET is a proto-oncogene located on chromosome 7q21, which encodes a transmembrane tyrosine kinase receptor (hepatocyte growth factor receptor). MET signals via RAS, PI3K/Akt, and stat pathways. Both copy number gain and true amplification of MET have been identified in NSCLC. MET amplification has been reported in about 1/5 of tumors in patients with EGFR mutation and acquired resistance to EGFR TKI. LKB1 (also called STK11) (located on 19p13) is a tumor suppressor gene that encodes for a serinethreonine kinase that phosphorylates AMPK, which plays a role in the cellular energy status. LKB1 regulates the cell polarity. Other tumorsuppressing properties of LKB1 may be mediated by inhibition of mTOR, inhibition of cell cycle, and activation of p53. LKB1 inactivation in lung cancer occurs mainly as a result of deletions or insertions or nonsense mutations leading to a complete absence of LKB1 protein, and LKB1 is the third most commonly altered gene in lung adenocarcinomas (5% of lung SqCC and 23% of adenocarcinomas), after TP53 and KRAS. FGFR1 is a critical member of the FGFR family of receptor tyrosine kinases. FGFR1 activation leads to downstream signaling via RAS/RAF-mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K)-AKT, STAT, and phospholipase Cγ. High-level amplification of FGFR1 had been reported in about 1/4 of SqCC. The amplification sensitizes the tumors to FGFR1 inhibition. Furthermore, FGFR1 amplification induced a strong FGFR1 dependency that could be exploited therapeutically, resulting in induction of apoptosis. Thus, FGFR1 amplification represents an opportunity for targeted therapy in SqCC. On 15q26, there is the insulin-like growth factor 1 (IGF-1) receptor (IGF-1R), which is an emerging target for cancer treatment. This aspect is due to its overexpression in many cancers, including NSCLC. IGF1R activation triggers downstream pathways, including the RAS/RAF/MAPK pathway and the PI3K pathway, leading to cell proliferation and inhibition of programmed cell death. In lung cancer, overexpression of IGF1R is more commonly seen in squamous cells. The discoidin domain receptor 2 (DDR2, located on 1q23) is a receptor tyrosine kinase that binds collagen. It has been shown to promote cell migration, proliferation, and survival when activated by ligand binding and phosphorylation. DDR2 mutations in lung cancer were identified specifically in about 1/20 of SqCC. SOX2 (3q26) is a transcription factor that plays a key role in the development of lung epithelium. SOX2 is one of the most frequent chromosome gain seen in a squamous cell with amplification in ∼20% of SqCC. It had been shown that RNA interference knockdown of SOX2 reduced cellular proliferation; however, SOX2 alone does not appear to be transforming, and SOX2 amplification may represent an important event that requires other additional events to be transforming. Recently, lung adenocarcinomas were reported to harbor a novel gene fusion involving the RET tyrosine kinase gene partnered with KIF5B (the kinesin family 5B gene) and others like CCDC6. RET fusion occurs in 1.4% of NSCLC, and 1.7% of lung adenocarcinoma, and the KIF5B-RET fusion induces an aberrant activation of RET kinase and is considered to be a potential new driver of lung adenocarcinoma. There are individuals with a specific phenotype (women, Asian, never smokers, adenocarcinoma type of bronchogenic carcinoma) and a particular genotype of tumor (EGFR gene amplification and/or somatic mutations in the kinase domain of the EGFR gene) that experience good response following treatment of the lung neoplasm with tyrosine kinase inhibitors (TKIs). Up to 1/5 of non-small cell lung cancer contains EGFR gene changes, and these patients do indeed benefit from TKIs. PCR-based EGFR mutational analysis and FISH amplification are the methods used to predict responsiveness with TKIs. The PCR method targets the detection of the most frequent EGFR mutations (exon 19 deletions and exon 21 L858R substitutions) accounting for about 9/10 of reported EGFR mutations. EGFR gene is amplified from either fresh-frozen tissue or formalin-fixed and paraffin-embedded tissue and targeting the gene sequence between exons 18 and exon 21 of the tyrosine kinase domain of the EGFR gene. The amplified sequences are then sequenced in a bidirectional fashion to identify mutations. Repeated sequencing of the tumor sample usually establishes a confirmatory method. FISH is used to detect EGFR gene amplification that may be both gene amplification (≥2 copies of EGFR comparing with the signal of a centromeric chromosome 7 control probe) and high polysomy (≥4 copies of EGFR per nucleus in >40% of cores). Conversely, patients with specific habit (smoking history) and mutations in the K-ras gene (KRAS) have a lack of response to EGFR inhibitors. KRAS gene mutations, mostly affecting codon 12 and codon 13, are present in about 1/4 of bronchogenic carcinoma of adenocarcinoma type. Pathology work is essential not only to determine the right diagnosis of lung cancer but also to identify the most suitable tumor tissue block for molecular studies. Diagnostic accuracy is necessary for pathology for correct treatment. In many reviews, the diagnostic accuracy of lung cancer is around 90%, which may be right from the statistical point of view, but is deleterious for the single patient. Striving for diagnostic accuracy is crucial in oncology as well as for non-oncologic diseases. Diagnostic accuracy may be improved by an awareness of the several and, frequently, multiple pitfalls that may lead to a diagnostic error of lung cancer. These pitfalls include crush artifacts, lymphoid tissue, non-small cell neuroendocrine tumors, basaloid variants of squamous cell carcinoma, etc. Thyroid transcription factor (TTF1) is, in the vast majority of reviews, the most useful marker of immunohistochemistry to detect an adenocarcinoma subtype in NSCLC-NOS cases. In fact, in the context of bronchial biopsy samples, TTF1 has a positive predictive value of 90% and a predictive accuracy of ~85%.

In this category, both inflammatory and neoplastic diseases play a significant role. One of the most frequent requisitions for consultation with a department of pediatric pathology or pathology for an adolescent or young adult is resection of part of pleura for chronic pleuritis due to spontaneous PNX. Mesothelial cells undergo hyperplastic response to injury or persistent irritation, which can be difficult to distinguish from welldifferentiated mesothelioma. The tumor suppressor gene, TP53, particularly its expression has been noted to be elevated in 70% of mesotheliomas but is normal in reactive mesothelium. Thus, this marker may be used in the immunohistochemical investigation of several pleural lesions ( Fig. 2 .45, 2.46, and 2.47).

Pleural effusion is defined as increase >15 ml of the fluid between visceral and parietal pleurae. In figure (e) there is pneumothorax-related type pneumocyte hyperplasia highlighted by S100 positivity (anti-immunostaining, ×100 original magnification), which is also supported by the positive immunostaining for thyroid transcription factor (TTF) (f: anti-TTF immunostaining, ×200 original magnification) and proliferative activity (g: anti-Ki67 immunostaining, ×100 original magnification). All immunostainings procedures have been carried out using the avidin-biotin complex. Echinococcosis of the pleura is shown in Figure (h Pleural plaques: Hyalinized fibrous tissue usually but not always associated with asbestos exposure, which are characteristically parietal or diaphragmatic. Pleural plaques may calcify.

• DEF: Air/gas detectable pleural pathology located between the peripheral margin of the lung and the chest wall, mediastinum, or diaphragm. • EPG: The etiology of PNX includes peri-pulmonic pneumonic breakthrough causes. These causes include external trauma through a perforation of the chest wall and parietal pleura, an internal trauma through an esophageal fistula, and an internal trauma through a perforated viscus (e.g., gastric ulcer).Visceral pleural breakthrough, non-syndromic subtype entails lung emphysema, Langerhans cell histiocytosis, lymphangioleiomyomatosis (LAM), CF, thoracic endometriosis, LIP, necrotizing pneumonia (e.g., Pneumocystis jirovcii), and light-chain deposition disease. The visceral pleural breakthrough, syndromic subtype comprises Marfan syndrome, Ehler-Danlos syndrome,and Birt-Hogg-Dube syndrome. • CLI: PNX is usually unilateral and occurs abruptly as chest pain, most often during physical exertion and is followed by shortness of breath, particularly in adolescents with (idiopathic) spontaneous PNX of tall males or in patients with CF. In some cases of spontaneous PNX, a thoracotomy is performed on a focus of fibrosis (so-called "apical cap"). • GRO: 1+ bulla/ae surmount PNX up to 1 cm in Ø. A hole may be observed in the pleural surface adjoining the bullae. Alternatively, a tear may be seen in the wall of one of the bullae. • CLM: There is a focus of fibrosis, and the overlying visceral pleura may contain air pockets. These findings correspond to interstitial emphysema and are termed blebs and are distinct from bullae, which represent enlarged alveolar spaces. There is an alveolar collapse, an accumulation of chronic inflammatory cells, and reactive mesothelial hyperplasia. The inflam-matory infiltrate is often rich in eosinophils, and the term "reactive eosinophilic pleuritis" has been proposed in the scientific literature. A fourth histologic component is represented by the reactive type II pneumocyte hyperplasia, which may be quite brisk sparking suspicion of adenocarcinoma in some cases. • DDX: Eosinophilic granuloma of the lung (pulmonary Langerhans cell histiocytosis) and eosinophilic pneumonia, which show deep infiltrates (not superficial), and vasculitis are the main differential diagnoses. Some small BV may be involved, but the process is limited to the subpleural region in the spontaneous PNX and does not involve deeper territories of the lung as seen in true vasculitis. • TRT: In cases, repeated PNX occurs, a procedure called "pleurodesis" may be proposed, which can obliterate the pleural cavity. The obliteration may be carried out surgically, by stripping the pleura, or medically, by the installation of sclerosing compounds such as talc or tetracycline. Pleurodesis may be contraindicated in patients, who will eventually necessitate lung TX because it will make the lung explant procedure challenging to perform. The identification of a fibrotic pleura with many birefringent crystals indicates that pleurodesis was undertaken in the past. Talc pleurodesis-associated neoplasia is rare but also needs to be taken into account before performing such a procedure. • PGN: Mesothelial hyperplasia may evolve into squamous metaplastic change if gas is maintained in the pleural cavity for many months, as was a frequent line of therapy for pulmonary TB. Squamous metaplasia may represent metaplasia of the mesothelium, progressive extension of metaplastic bronchial epithelium through a bronchopleural fistula or skin implantation. This metaplastic change has been noted to be an underlying disorder for progression to malignancy. In patients with CF, focal replacement of the mesothelium by ciliated columnar or squamous epithelium has been found. This aspect is likely due to a rupture of bronchiectatic abscesses contributing to the pathogenesis of PNX in this disease.

In some cases, the label of hemopneumothorax is used, when the local blood vessels are also damaged. Iatrogenic forms of PNX occur when the air is deliberately introduced into the pleural sac for the treatment of chronic TB allowing collapsing and resting the lung (i.e., artificial PNX). In thoracic surgery, the pleural sac is often opened and specifically approved to be filled with air as well. PNX is also divided in the "open" and "closed" subtype being the former a PNX with aperture remaining patent and air pass freely into and out of the sac, while the latter shows progressive resorption of the air. Importantly, the gradual adsorption of air ensues over a few weeks, O 2 first and nitrogen later. The valve PNX may sometimes occur and consists of a PNX that allows air to enter, but not to escape. This clinical situation, which is called pressure or tension PNX, constitutes a medical emergency because the increased pressure displaces the structures of the mediastinum progressively to the opposite side similarly to a diaphragmatic defect. The most striking differential diagnoses are bullous emphysema, LCH, and cystic LAM.

There are very few tumors that have dominated the epidemiological platform in a specific age group in the past, but currently, mesothelioma is being diagnosed at an earlier age than before, and an increase to asbestos fibers exposure is overwhelming particularly in regions where asbestos fibers are still used or manufactured. Among tumors, a solitary fibrous tumor of pleura, benign mesothelioma, and malignant mesothelioma will be considered.

• DEF: Benign mesenchymal tumor of pleura, usually visceral pleura, often pedunculated, and of interstitial dendritic cell origin, without apparent nexus to asbestos exposure. • SYN: Solitary fibrous mesothelioma.

• EPI: Uncommon in adults but rare in children, ♂:♀ = 1:1. Very few pediatric case reports have been reported, including in the pleura of a 7-year-old boy, in the mesentery of a 6-yearold boy, or in the orbit of a 15-year-old child (Penel et al. 2012 ). • GRO: Well circumscribed, ±encapsulated, firm, lobulated, neoplasm harboring a whirled cut surface. • CLI: (1) IGF-related hypoglycemia (paraneoplastic hypoglycemia)-manifesting SFT, (2) hypertrophic pulmonary osteoarthropathy (HPO)-manifesting SFT (digital clubbing), (3) mass-related symptoms (cough, chest pain, dyspnea, effusion), and (4) asymptomatic SFT. • CLM: Four microscopic aspects characterize this tumor, including: 1. "Patternless" pattern, described by a tangled network of fibroblast-like cells with deposition of copious reticulin and collagen fibers ("ropey" collagen) and cellularity varies from densely cellular to edematous to densely collagenous with some keloidal appearance 2. Wavy neuroid pattern 3. Storiform/herringbone 4. Hemangiopericytomatous • IHC: (+) CD99, (+) BCL2, (+) CD34 (positive triad) and (+) VIM as well as (−) S100, CKs, SMA, DES, FXIIIa, and Coll-IV. • DDX: Synovial sarcoma, which is (+) CD99, (+) BCL2, but (−) CD34. • TEM: Non-mesothelial architecture.

• TRT: Usually cured by simple excision and paraneoplastic hypoglycemia will vanish. • PGN: Recurrence in up to 1/5 of cases with "aggressive" behavior showing repeated recurrences. Malignancy has been identified in SFT showing high expression of TP53 and high proliferation rate detected by MIB1 (Ki67) (Box 2.24).

Benign mesothelial solitary tumor (aka pleural fibroma) seems to be relatively rare in pleural cavity, differently from the peritoneal cavity, where it is more common. The benign mesothelioma manifests usually as soft friable, well-circumscribed, mottled, gray/pink/yellow mass with papillary processes lined by one or several lay-ers of cuboidal mesothelial cells without atypia histologically. It is important to emphasize here that the amphiboles are more carcinogenic than chrysotile asbestos properly in consideration of the next paragraph.

• DEF: Malignant pleural mesothelial tumor (MPM). • EPI: Rare, <5% of presenting cases are children, and less than 300 cases of such have been published in the literature (Scharf et al. 2015 ). • EPG: ~2/3 of malignant mesotheliomas are related to asbestos exposure, and chronic asbestos exposure carries a 2-3% risk of mesothelioma -risk, which is not increased by tobacco smoking. Long latency between exposure and tumor onset, 25-45 years, and asbestos bodies more commonly found in the lung (≠ ferruginous bodies). In the pediatric cases, there is no apparent association with asbestos or radiation exposure. An example of pediatric MPM has been reported after in utero isoniazid exposure took place. Moreover, malignant mesothelioma has been found in a child with ataxia-telangiectasia syndrome, which is a hereditary disorder characterized in part by susceptibility to malignancy. • GEN: Deletion of chromosomes 1, 3, 6, 9, and 22; TP53 and P16 genes changes. • CLI: Pulmonary symptoms are related to the extension of the tumor in the pleura opposing a normal movement of the pleura.

• GRO: Multiple gray or white ill-defined nodules are diffusely thickening of pleura, which may grow extensively to fill pleural space, producing effusion and encasing lung. • CLM: (1) Epithelial type, (2) spindle or sarcomatoid type, and (3) mixed type. 1. Epithelial type, showing papillae or pseudoacini or even solid nests of cuboidal, columnar, or flattened cells (tubular-papillary, glandular-acinar, sheets/solid, and mixed). 2. Spindle or sarcomatoid type with more nodularity and less plaque-like, high cellularity, nuclear atypia, high MI, interweaving bundles of spindle cells, and common areas of hemorrhage, necrosis, and cystic change. In case of a significant amount of collagen, the sarcomatoid-type of malignant mesothelioma has been designated "desmoplastic mesothelioma." 3. Mixed type (biphasic).

• IHC: (+) CALR, D2-40, K5/6, WT-1, thrombomodulin (CD141).

Calretinin is stronger in both cytoplasm and nuclei in the sarcomatoid type (+++) while is less strong (+) in the epithelial type of malignant mesothelioma. Other markers are much useful in differentiating between the two types of malignant mesothelioma.

• TEM: Long slender microvilli of the neoplastic mesothelial cells (≥15 times than Ø). • DDX: Bronchogenic adenocarcinoma, metastasis, synovial sarcoma, etc. • TRT: Chemotherapy alone is the first choice for patients with stages I-IV disease who are not candidates for surgery and for patients with sarcomatoid histology, which does not usually occur in youth. • PGN: 1-YSR: ~50%; sarcomatoid type has a worse prognosis than epithelial type.

Distinguishing malignant mesothelioma from adenocarcinoma may be very challenging. However, some features are more distinctive of one entity, and some other features are more prone to suggest the other entity. Mesothelioma produces hyaluronic acid (intracellular and extra-Box 2.24 "Aggressive" Signs of SFT • Size: Ø > 5 cm • Lack of pedicle ("non-pedunculated SFT") • Hypercellularity accompanied by cellular pleomorphism and/or giant cells • Hyperdivision of the cells (high mitotic index with MI > 4/10 HPF) • Necrosis Notes: MI, mitotic index. cellular) which can be stained with alcian blue in a hyaluronidase sensitive manner, while mucicarmine or PAS positive droplets in cells may strongly suggest adenocarcinoma. Moreover, mesothelial cells are keratin, VIM, EMA, S100 positive, and almost always CEA, Leu-M1 (CD15), Ber-EP4 (anti-EpCAM) negative, while adenocarcinoma cells are steadily keratin, EMA, CEA, Leu-M1, and Ber-EP4 positive. HMFG-2 stains only cell membranes of mesothelial cells but shows cytoplasmic staining for adenocarcinoma. Mesothelial cells are also negative for p63, CD117, K20, and MUC4. In Box 2.25 there is a useful diagnostic panel to distinguish malignant mesothelioma from adenocarcinoma.

The criteria of malignancy are branching glands, extensive storiform pattern, lack of zonation, large cell groupings of neoplastic cells, a marked cellular atypia/pleomorphism, the presence of necrosis, the identification of papillae, and the obvious stromal invasion. Overall, the features favoring mesothelioma vs. carcinoma are (+) acid mucopolysaccharide, which is inhibited by hyaluronidase, (+) CALR, D2-40, WT-1, K5/6, and CD141, (−) TTF-1, CEA, B72.3 and BerEp4, p63, CD117, K20, MUC4, CD15, perinuclear rather than peripheral staining for keratins, and long and slender microvilli and abundant tonofilaments but absent microvillous rootle and lamellar bodies on TEM.

PTLD are uncommon complications of transplantation and represent a heterogeneous group of diseases that can lead to significant morbidity and mortality. We investigated the frequency of anatomic site occurrence, the subtypes of PTLD, and the Epstein-Barr virus (EBV) status of the malignant cells. The EBV, also called human herpesvirus 4, is one of eight known human herpesvirus types in the herpes family. EBV is one of the most diffuse viruses in humans. EBV is infamously best known as the cause of infectious mononucleosis and the etiologic agent of the "first kissing" disease of the adolescents or "the kissing disease" as first described in the 1920s by Thomas Peck Sprunt and Frank Alexander Evans, who coined the term "infectious mononucleosis" (Sprunt and Evans, 1920) . We reviewed the surgical pathology of 53 cases of PTLD in 47 consecutive patients with solid organ transplantation at the University of Alberta, Edmonton, AB, Canada (Yu et al. 2010) . The anatomic occurrence of the lesions, subtype of PTLD, and the EBV status of the malignant cells were studied. In the 47 patients (11 children, 36 adults, age mean = 41, range 2-71, ♂:♀ = 3:2) with solid organ transplants (19 kidneys, 10 livers, and 9 each of hearts and lungs), 2 (4%) patients developed early PTLD with plasmacyte hyperplasia (E-PTLD) and 19 (36%) patients with polymorphic (PM) PTLD and 28 (53%) patients had monomorphic (MM) subtype of predominantly diffuse large B-cell lymphoma and 4 (7%) patients of Hodgkin disease (HD). The aerodigestive tract (ADG) represented the largest involved group, n = 19 (36%) (GI = 11, respiratory tract = 8), with 8 cases (42%) of PM and 11 (58%) MM-PTLD. Six patients had multiple organ involvement. In 35 patients tested by EBV-ISH, 26 (74%) patients were found positive (17 MM-HD, 9 PM), and 9 (26%) patients were EBVnegative (7 MM, 2 PM). The EBV status was compared to PTLD subtype but no statistical significance was observed. In an EBV-negative case, polyomavirus was detected. This study confirmed the heterogeneity of PTLD and the involvement of Notes: CALR, calretinin; WT-1, Wilms tumor-1; K5/6, keratin 5/6; TTF-1, thyroid transcription factor, CEA, carcinoembryonic antigen; B72.3, monoclonal antibody that recognizes tumorassociated glycoprotein 72 (TAG-72), which is a mucin-like carbohydrate and protein complex on the surface of numerous cancer cells, Napsin A is a functional aspartic proteinase playing an important role in identifying primary lung ACA. The acronym "Caldinek" may be used for the positive markers in PMM (Calretinin, D2-40, nephroblastoma antigen, and keratins) multiple anatomic sites. The significant manifestation of PTLD in the aerodigestive tract is crucial and may be related to the immunologic reactions in mucosa-associated lymphoid tissues (MALT) of these sites. EBV continues to be a critical etiologic agent in the development of PTLD. The emerging EBV-negative PTLD cases may warrant an investigation into other causal agents with different mechanisms of malignant transformation. Fine needle aspiration cytology plays a major in the diagnostics of pulmonary disorders (Figs. 2.48 and 2.49). Contaminants of percutaneous FNA include cutaneous squamous cells, mesothelial cells, skeletal muscles, fibroblasts/fibroconnective tissue, and hepatocytes. Mesothelial cells are characterized by flatness, cohesiveness, uniformity, and "windows"-ness.

The uniformity is explicit in showing round to oval nuclei with small nucleoli, a moderate amount of cytoplasm. Conversely, reserve cell hyperplasia is characterized by the cohesiveness of packed cells, small cell size with scant cytoplasm, nuclear molding with smudged dark chromatin, but no mitosis or necrosis. Some structures need to be kept in mind and recognized cytologically. Creola body is a cluster of reactive bronchial cells -ciliated columnar cells (usual nuclear features of bronchial cells, cilia of bronchial cells, ±eosinophils) found in the sputum of some asthmatic patients. Curschmann spiral is a microscopic finding in the sputum of asthmatic patients. Charcot-Leyden crystal is the by-product of eosinophilic degeneration. Curschmann's spiral is found in lavage fluid a b c d of asthmatic patients, and the Papanicolaou staining will highlight a reddish core with a fuzzy margin. To this margin, numerous cells are attached secondarily. The spiral can reach 1 mm in length. It is not uncommon to see contamination with vegetable cells in some FNAs. Sarcoidosis features include aggregates of epithelioid histiocytes, MNGC, and lymphocytes.

The mediastinum is located in the thoracic cavity in the center between the two lungs. It is surrounded by loose connective tissue, as an undelimited region that contains a group of structures within the thoracic cavity. The mediastinum contains the heart, the cardiac outflow tractderived blood vessels, the esophagus, the trachea, the phrenic and cardiac nerves, the thoracic duct, the thymus, and the lymph nodes of the central chest. Anatomists and surgeons divide the mediastinum into three compartments. The mediasti-num is split into three compartments, including anterior, middle, and posterior. However, such a system of compartmentalizing may have deficiencies. The assessment performed on a lateral radiograph of the chest does not have real and definite fascial planes. Also, several disorders that may present as mediastinal masses cross boundaries or arise in more than one compartment. On the other hand, the practice of assigning a mediastinal mass to a specific chamber is still convenient because such a method enables the physician to formulate a manageable differential diagnosis. It effectively directs further imaging workup, and it yields valuable information, particularly for surgical planning. Numerous methods for classifying the mediastinal compartments have been published. The most typical of these methods include the Shields' classification schema, the Fraser and Pare, Felson, Heitzman, Zylak, and Whitten models, which may have more a radiologic practice than clinical practice. These schemata and classifications can be retrieved in specific textbooks. Several aspects contribute to make the terminology of this field typical of Babelic confusion.

There is quite a lot of confusion because there is considerable overlap. Terminological differences and diverse methodologies have resulted in confusion among physicians. In the following paragraphs, we are going to illustrate to the best of our knowledge the pathology occurring in the anterior mediastinum, middle mediastinum, and posterior mediastinum.

The anterior mediastinum can have thymomas that are discussed in the hematologic chapters and non-thymomas anterior mediastinal pathology, which includes thyroid tissue masses and lymphadenopathy. Thyroid masses in the anterior mediastinum can arise either from ectopic thyroid tissue or via an extension of the orthotopic thyroid gland tissue into the anterior mediastinum. The most common pathology is a cervical thyroid goiter which extends into the substernal location. Overall, the lymphadenopathy is the most common cause of mediastinal masses. The characteristics of the patient (age, sex, medical history, etc.) and the clinical setting usually determine the roots of the lymphadenopathy. The differential diagnosis should always include metastatic sarcoma (rhabdomyosarcoma)/carcinoma, malignant lymphoma of Hodgkin type and non-Hodgkin type, and infectious/inflammatory conditions, especially granulomatous processes such as tuberculosis, histoplasmosis, and sarcoidosis. Most common types of lymphomas that can involve the mediastinum are the nodular sclerosis Hodgkin lymphoma, the lymphoblastic lymphoma, and the diffuse large cell lymphoma. Chiefly in pediatrics, some other small round blue cell tumors can mimic malignant lymphomas, including neuroblastoma, embryonal rhabdomyosarcoma, primitive neuroectodermal tumor/Ewing sarcoma, seminoma, and metastatic small cell carcinoma. The question to dispute is mainly a morphological issue if the biopsy is small or has been crushed. The classical Hodgkin lymphoma, nodular sclerosis variant shows marked fibrosis at low power, which is typical of the lesion. The use of the 20× ocular usually allows the identification of the neoplastic Reed-Sternberg cells, Reed-Sternberg cell variants, and Hodgkin cells. The Reed-Sternberg cells, which will be discussed in more detail in the hematologic chapter, have a distinctive multilobed nucleus and prominent nucleoli, while the background shows a mixture of benign inflammatory cells. The low power examination is also useful in identifying the sarcoidosis with the effaced lymph nodes showing numerous confluent non-necrotizing epithelioid granulomas with surrounding fibrous tissue. Histoplasmosis needs to be ruled out using a silver staining (histochemical special stain) to highlight multiple black yeast forms of Histoplasma capsulatum. In the anterior mediastinum, lymphangiomas and hemangiomas may also occur in addition to the relatively rarer occurrences of lipomas and sarcomas. Germ cell tumors arise almost exclusively from primitive, undifferentiated cells generally found in the sexual organs but which can get sprinkled in various other sites of the body during embryogenesis, especially along the midline (retroperitoneum, skull base other than mediastinum). Germ cell tumors occur at any age, but usually, adolescents and young men are most often involved. Histologically, germ cell tumors are classified in seminomas ("pure seminoma") and non-seminomatous germ cell tumors (NSGCTs). The latter entity includes teratoma, choriocarcinoma, yolk sac tumor, embryonal carcinoma, and mixed germ cell tumors. The histology of the seminoma and NSGCTs is not dissimilar from the GCTs of the testis and ovary and will be highlighted in the chapter in detail. Typically, GCTs spread via lymphatics but can metastasize anywhere especially the choriocarcinoma type. Since testicular germ cell tumors can metastasize to the mediastinum, it is mandatory to study entirely male adolescents and young men with mediastinal masses for a testicular imaging investigation. Serum alpha-fetoprotein (AFP), which increases notably in case of yolk sac tumor, and human chorionic gonadotropin (HCG), which increases with choriocarcinoma, also need to be investigated both serologically and by immunohistochemistry. Moreover, thymic cysts and cysts of the parathyroid gland can also occur and need to be taken into the differential diagnosis.

In this category, mediastinal lymphadenopathy as illustrated above and pericardial and bronchogenic cysts play a significant role.

In this part the mediastinum gastroenteric cysts, which are a maldevelopment defect, and neurogenic tumors play a key role. Neurogenic tumors are a typical cause of a posterior mediastinal mass, and they rarely arise elsewhere in the mediastinum. Most of these tumors are benign, with the malignant ones generally occurring in younger patients. They are classified as tumors of the sympathetic nervous system (neuroblastoma, ganglioneuroblastoma, and ganglioneuroma) and tumors of peripheral nerve and nerve sheath (schwannoma, neurofibroma, and malignant schwannoma or malignant nerve sheath tumors). Both tumors of the sympathetic nervous system and tumors of the peripheral nervous system will be illustrated in detail in other chapters (soft tissue and nervous system). Briefly, the neuroblastoma is an undifferentiated tumor composed of small cells with a high nucleus: cytoplasm ratio, variable Schwannian stroma, and a variable number of mitoses and karyorrhexis. The schwannoma is, conversely, a lobulated, encapsulated mass with a right capsule and homogeneous white-yellowish cut surface and constituted of normal spindled cells with no significant mitotic activity.

• RSP-1 Which sequence corresponds to the right progression of the different phases of intrauterine lung development? (a) Canalicular phase → saccular phase → alveolar phase (b) Pseudoglandular phase → saccular phase → alveolar phase (c) Pseudoglandular phase → canalicular phase → saccular phase → alveolar phase (d) Canalicular phase → saccular phase → alveolar phase • RSP-2 The mother brings a 2-year-old boy to the pediatrician with a history of recurrent pneumonia. Mother does not live with the father and has multiple partners. A few animals live in the house including a cat, a dog, and a parrot. On physical examination, wheezing and crackles are heard. Moreover, digital clubbing is recognized. Blood eosinophilia is not noted, and no signs of child abuse are evident. What is the most likely diagnosis? (a) Cystic fibrosis (b) Psittacosis (c) Human immunodeficiency virus (HIV) infection (d) Lung sequestration (e) Allergic bronchopulmonary aspergillosis • RSP-3 A 3-year-old girl, ex premature baby, who received some oxygen at birth, is brought by the parents to the pediatrician with a history of relapsing pneumonia of the left lung. Imaging and bronchography show that the area involved does not fill contrasting with the surrounding parenchyma. What is the most likely diagnosis? 

Fetal thoracic lesions

Management of the fetus with a cystic adenomatoid malformation

Fetal surgery for cystic adenomatoid malformation of the lung

Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature

Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure

Contemporary optimized practice in the management of pulmonary sarcoidosis

Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis

Diagnostic usefulness and challenges in the diagnosis of mesothelioma by endoscopic ultrasound guided fine needle aspiration

ABCA3 as a lipid transporter in pulmonary surfactant biogenesis

The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus

Lupus pernio de la face; synovites fongueuses (scrofulo-tuberculeuses) symétriques des extrémités superieures

Radial alveolar count as a tool for the estimation of fetal age

Cannabis smoking in 2015: a concern for lung health?

An electron microscope study of basal melanocytes and highlevel clear cells (Langerhans cells) in vitiligo

The pathology of mediastinal masses. Queen's University at Kingston

En hidtil ikke beskreven hudaffektion)

BRCA1/2 mutation screening and LOH analysis of lung adenocarcinoma tissue in a multiple-cancer patient with a strong family history of breast cancer

Pulmonary alveolar proteinosis

Asbestos-related disease in South Africa: the social production of an invisible epidemic

Successful treatment of severe juvenile microscopic polyangiitis with rituximab

Worldwide overview of the current status of lung cancer diagnosis and treatment

Advances in treatment of lung cancer with targeted therapy

Precision medicine for lung cancer: role of the surgical pathologist

Verifying the role of surgical pathologists in the precision medicine of lung cancer

Comprehensive molecular profiling of lung adenocarcinoma

Centennial: Koch's discovery of the tubercle bacillus

Treasure Island (FL): StatPearls Publishing

ABCA3 is critical for lamellar body biogenesis in vivo

Pulmonary lymphangitis carcinomatosa due to adenocarcinoma arising from choledochal cyst: report of an autopsy case

Diagnosis of severe silicosis in young adults working in stone polishing and mining in Minas Gerais, Brazil

EGFR antagonists in cancer treatment

Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-smallcell lung cancer: a randomised, double-blind, phase 3 study

Pulmonary sequestration and related congenital bronchopulmonary-vascular malformations: nomenclature and classification based on anatomical and embryological considerations

Current histological diagnosis of lymphomatoid granulomatosis

The cytologic evaluation of lipid-laden alveolar macrophages as an indicator of aspiration pneumonia in young children

Recurrent aspiration in children: lipid-laden alveolar macrophage quantitation

Pulmonary aspiration and lipid-laden macrophages: in search of gold (standards)

Airway reactivity following repeated milk aspiration in rabbits

Aspiration: a common event and a clinical challenge

Time course of lipid-laden pulmonary macrophages with acute and recurrent milk aspiration in rabbits

Acute eosinophilic pneumonia

Diminished radial count is found only postnatally in Down's syndrome

The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease

Tracheal agenesis: optimization of computed tomography diagnosis by airway ventilation

Hyperplasia of pulmonary neuroendocrine cells in infancy and childhood

Les formations vesiculeuses dans les glandes endocrines

EGFR mutations and lung cancer

Molecular diagnostics of lung carcinomas

Diagnostic value of PET/ CT in differentiating benign from malignant solitary pulmonary nodules

Stress response and its relationship to cystic (pseudofollicular) change in the definitive cortex of the adrenal gland in stillborn infants

Guidelines for mineral fibre analyses in biological samples: report of the ERS working group

Thoracic sarcoidosis: the spectrum of roentgenologic appearances

ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme

Genetic interstitial lung disease

Towards the elimination of paediatric tuberculosis in high-income, immigrant-receiving countries: a 25-year conventional and molecular epidemiological case study

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Treasure Island (FL): StatPearls Publishing

Pulmonary arteriovenous fistulas

Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK

Classification of diffuse lung disease in older children and adolescents: a multi-institutional study of the Children's interstitial lung disease (chILD) pathology working group

Pediatric interventional pulmonology

Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype

Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced nonsmall-cell lung cancer

1797-1876) and the first reports of lymphangitis carcinomatosa

Utility of the QuantiFERON-TB gold in-tube assay for the diagnosis of tuberculosis in Moroccan children

Philadelphia: Lippincott-Raven

The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood

The anatomy of the developing lung. London: Heinemann Medical

The history of infectious mononucleosis

Longterm cardiovascular consequences of undiagnosed intralobar pulmonary sequestration

Childhood tuberculosis: an overview

Children's interstitial and diffuse lung disease research network (chILDRN). Diffuse lung disease in biopsied children 2 to 18 years of age

Chest roentgenology. Philadelphia: WB Saunders

ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol

The normal chest. Diagnosis of diseases of the chest

The mediastinum. Fraser and Paré's diagnosis of diseases of the chest

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

Surfactant composition and function in patients with ABCA3 mutations

Tolerability of inhaled N-chlorotaurine in the pig model

Chronic E-cigarette use increases neutrophil elastase and matrix metalloprotease levels in the lung

Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion

Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series

EXIT (ex utero intrapartum treatment) in a growth restricted fetus with tracheal atresia

Hundert Jahre Pfeiffersches Drusenfieber [100 years of Pfeiffer's glandular fever

CT and histopathological correlation of congenital cystic pulmonary lesions: a common pathogenesis?

Erratum in: Nat Rev Dis Primers

Thrombocytopenia-absent-radius syndrome in a child showing a larger 1q21.1 deletion than the one in his healthy mother, and a significant downregulation of the commonly deleted genes

Middle lobe syndrome: a review of clinicopathological features, diagnosis and treatment

Mortality trends in asbestosis, extrinsic allergic alveolitis and sarcoidosis in England and Wales

Clinical presentation of asbestosis with intractable pleural pain in the adult child of a taconite miner and radiographic demonstration of the probable pathology causing the pain

Nicht spezifische interstitielle Pneumonie

The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects

The mediastinum

A cautionary note about congenital cystic adenomatoid malformation (CCAM) type 4

Anomalous systemic arterial supply to normal basal segments of the left lower lobe: a report of two cases

2013 by the American College of Cardiology Foundation ISSN

Pharmacogenetic and germline prognostic markers of lung cancer

Observationes aliquot de arteria singulari pulmoni concessa

Evaluation of the Reid index in infants and cases of SIDS

Personalized medicine for lung cancer: new challenges for pathology

Die Ätiologie der Tuberkulose

The clinical spectrum of pulmonary aspergillosis

En ny og spesifikk kutan-reaksjon ved Boecks sarcoid. En foreløpig meddelelse

Post-transplant lymphoproliferative disorders

Primary epithelial lung malignancies in the pediatric population

Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies

Lipid-laden alveolar macrophages as an indicator of aspiration pneumonia

A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group

Epidemiologic critique of literature on post-transplant neoplasms in solid organ transplantation

Hyaline membrane disease: a pathological study of 55 infants

Revisit on congenital bronchopulmonary vascular malformations: a haphazard branching theory of malinosculations and its clinical classification and implication

Transcatheter occlusion of the isolated scimitar vein anomaly camouflaged under dual pulmonary venous drainage of the right lung by the Amplatzer ductal Occluder

A systematic classification of the congenital bronchopulmonary vascular malformations: dysmorphogeneses of the primitive foregut system and the primitive aortic arch system

Role of high-resolution chest computed tomography in a child with persistent tachypnoea and intercostal retractions: a case report of neuroendocrine cell hyperplasia

Biomarker testing and time to treatment decision in patients with advanced nonsmallcell lung cancer

Congenital vascular lesions of the lungs

Expanded Prader-Willi syndrome due to chromosome 15q11.2-14 deletion: report and a review of literature

An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation

KRAS mutations affect prognosis of nonsmall-cell lung cancer patients treated with first-line platinum containing chemotherapy

Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis

KRAS mutations as prognostic and predictive markers in nonsmall cell lung cancer

Surveillance for silicosis deaths among persons aged 15-44 years -United States

The association between alcohol, marijuana, illegal drug use and current use of E-cigarette among youth and young adults in Canada: results from Canadian tobacco, alcohol and drugs survey 2017

Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation

The aspiration of stomach contents into the lungs during obstetric anesthesia

Senior RM, editors. Fishman's pulmonary diseases and disorders

Malignant mesothelioma in Japan: analysis of registered autopsy cases

An 11-year-old boy with silico-tuberculosis attributable to secondary exposure to sandstone mining in Central India

Pulmonary vascular anomalies: a review of clinical and radiological findings of cases presenting with different complaints in childhood

A national internetlinked based database for pediatric interstitial lung diseases: the French network

RespiRare and the French sarcoidosis groups. Lung sarcoidosis in children: update on disease expression and management

Paediatric sarcoidosis

Curschmann's spirals in pleural and peritoneal effusions

The familial occurrence of hypoplastic right lung with systemic arterial supply and venous drainage "scimitar syndrome

Pediatric lung lesions: a clinicopathological study of 215 cases

Pediatric lung lesions: a clinicopathological study of 215 cases

Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant

Diffuse malignant mesothelioma

Cystic lung lesions in the pediatric and adult population: surgical experience at the Brompton hospital

Cutaneous bronchogenic cyst over the sternum

On the mechanical factors which determine the output of the ventricles

The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics

析 [clinical, radiologic, pathological features and diagnosis of 14 cases with interstitial lung disease in children

Mesothelioma mortality in Brazil

Solitary fibrous tumors and so-called hemangiopericytoma

Targeting the c-Met signaling pathway in cancer

Reaction of oils and fats in the lung

Identification of driver mutations in lung cancer: first step in personalized cancer

Lower accessory pulmonary artery with intralobar sequestration of lung; a report of seven cases

Infections and immunodeficiency in down syndrome

Asbestos is still with us: repeat call for a universal ban

Asbestos is still with us: repeat call for a universal ban

Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis

Interobserver and intraobserver variability in the calculation of the lipid-laden macrophage index: implications for its use in the evaluation of aspiration in children

Incidental diagnosis of congenital tracheal stenosis in children with congenital heart disease presenting for cardiac surgery

Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)

Primary malignant pulmonary tumors in children: a review of the national cancer data base

Acute eosinophilic pneumonia in a New York City firefighter exposed to world trade center dust

Fatal massive hemoptysis secondary to intralobar sequestration

The spectrum of pulmonary sequestration

Lung sequestration: report of seven cases and review of 540 published cases

Malignant pleural mesothelioma in a child

Étude sur le lupus pernio et ses rapports avec les sarcoides et la tuberculose

Congenital fibrosarcoma as cause for fetal anemia: prenatal diagnosis and in utero treatment

Down syndrome: patterns of disturbed lung growth

Tolerability of inhaled N-chlorotaurine in an acute pig streptococcal lower airway inflammation model

Bronchopneumonia disguising lung metastases of a painless central chondrosarcoma of pubis

Mapping a method for systematically reviewing the medical literature: a helpful checklist postmortem protocol of human immunodeficiency virus (HIV)-related pathology in childhood

Fatal circumstances of human herpesvirus 6 infection: transcriptosome data analysis suggests caution in implicating HHV-6 in the cause of death

Holoprosencephalypolydactyly (pseudotrisomy 13) syndrome: case report and diagnostic criteria

Clinical characteristics and follow up of down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn

Lung cancer in 2013: state of the art therapy for metastatic disease

Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation

Congenital vascular lesions of the lungs

Primary tumors and cysts of the mediastinum

Mononuclear leukocytosis in reaction to acute infection

Cystic lung disease in infants and children

Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum

Pulmonary langerhans cell histiocytosis

The proximal chromosome 14q microdeletion syndrome: delineation of the phenotype using high resolution SNP oligonucleotide microarray analysis (SOMA) and review of the literature

International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma

The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification

Perinatal management of congenital cystic lung lesions in the age of minimally invasive surgery

Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray

Pneumopathie interstitielle non spécifique: une entité rare chez l'adolescent [Non-specific interstitial pneumonia: a rare clinical entity in adolescents

Congenital tracheal malformations

Grading of pulmonary vascular lesionsa reappraisal

A diagnostic approach to mediastinal abnormalities

Use of DNA estimation for growth assessment in normal and hypoplastic fetal lungs

Fetal lung hypoplasia: biochemical and structural variations and their possible significance

Pulmonary fibrosis: pathogenesis, etiology and regulation

AXL kinase as a novel target for cancer therapy

Integrating mechanisms of pulmonary fibrosis

Anomalous systemic arterial supply to normal basal segments of the left lower lobe

Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD)

Quantitation of lipid-laden macrophages in evaluation of lower airway cytology specimens from pediatric patients

The hepatocyte growth factor/ c-Met signaling pathway as a therapeutic target to inhibit angiogenesis

Usual interstitial pneumonia in an adolescent with ABCA3 mutations

Posttransplantation lymphoproliferative disorders (PTLD): clinicopathologic and morphologic studies. Presentation at the 2010 Annual General Meeting of the Canadian Association of Pathologists/Association Canadienne des Pathologistes

EGFR-mutated lung cancer: a paradigm of molecular oncology

English disease": historical notes on rickets, the bone-lung link and child neglect issues

Correlative anatomy and computed tomography: a module on the mediastinum

• RSP-5 Adult respiratory distress syndrome (ARDS) can present in both childhood and adulthood. Which of the following morphologic features are NOT present in ARDS? (a) Hyaline membranes located in the alveoli (b) Decreased permeability of the capillary endothelial cells of the lungs (c) Hyperplasia/proliferation of type II pneumocytes (d) Alveolar wall damage (e) Pulmonary edema • RSP-6 Which of the following statements on human parainfluenza viruses (HPIVs) is NOT correct? (a) HPIVs are single-stranded, enveloped DNA viruses of the Paramyxoviridae family. (b) Four serotypes are known, and they cause respiratory illnesses in children and adults. (c) HPIVs bind and replicate in the ciliated epithelial cells of the upper and lower respiratory tract. (d) Seasonal HPIV epidemics account for 40% of pediatric hospitalizations for lower respiratory tract illnesses and 75% of croup cases. (e) HPIVs are associated with a broad spectrum of illnesses which include otitis media, pharyngitis, conjunctivitis, croup, tracheobronchitis, and pneumonia. (f) Immunity resulting from the disease in childhood is incomplete, and reinfection with HPIV accounts for 15% of respiratory illnesses in adults. • RSP-7 Which of the following statements on primary tuberculosis is NOT correct? (a) An incubation period of 2-10 weeks follows the initial infection. (b) Presenting symptoms include slightly elevated but persistent temperature, weight loss, fatigue, irritability, and malaise. (c) Chest X-ray shows diffuse lobar infiltration of the right middle lobe. (d) Mediastinal lymph node involvement is common. (e) Tuberculous pleurisy is a late complication. • RSP-8 Pulmonary hemosiderosis shows hemosiderin-laden macrophages histologi-cally in alveolar lumina. There is also shedding and hyperplasia of alveolar epithelial cells. Marked alveolar capillary congestion can be seen. Pulmonary hemosiderosis is evidenced by which special stain? (a) Gram stain (b) Von Kossa stain (c) Perls' Prussian blue stain (d) Picro-sirius (e) Masson Goldner stain • RSP-9 The pathology of alveolar capillary dysplasia (ACD) with misalignment of the pulmonary veins has specific features in addition to the misalignment of the pulmonary veins. Generally, the pulmonary veins accompany pulmonary arteries within the same adventitial sheath and become parts of the bronchovascular bundles within the centers of the lobules. In ACD with misalignment of the pulmonary veins, the pulmonary veins reside within the interlobular septa at the peripheries of the lobules. Which of the following statements does NOT belong to ACD? (a) A general reduction of alveolar capillaries (b) Prominent thickening of the alveolar septa, containing fibroblasts and myofibroblasts and extracellular matrix and centrally placed alveolar capillaries that are at least several cell widths detached from the nearest alveolar spaces; (c) Intra-alveolar hyaline membranes (d) Striking pulmonary vascular changes (e) Variable degrees of alveolar underdevelopment • RSP-10 An 8-year-old male presented to his family physician complaining of dyspnea, weight loss, and lethargy. He was referred to a pediatric surgeon of a tertiary hospital with expertise in neoplastic lung disease. A chest radiograph and CT scan demonstrated a large right-sided chest mass that appeared to be arising from the upper lobe. There was no known exposure to asbestos or radiation. Neither intra-nor extrapulmonary sequestration were diagnosed in his infancy. A needle biopsy was performed, and the hematoxylin and eosin staining of the histology is shown here: